Background  	Background  	 NN	O
The  	The  	 DT	O
cysteine-loop  	cysteine-loop  	 JJ	B-NP
family  	family  	 NN	I-NP
of  	of  	 IN	I-NP
ligand  	ligand  	 FW	I-NP
gated  	gated  	 FW	I-NP
ion  	ion  	 FW	I-NP
channels  	channels  	 FW	I-NP
( 	( 	 -LRB-	O
LGIC 	LGIC 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
comprised  	comprised  	 VBN	O
of  	of  	 IN	O
receptors  	receptors  	 NNS	B-NP
with  	with  	 IN	O
pentameric  	pentameric  	 JJ	B-NP
quaternary  	quaternary  	 JJ	I-NP
structure  	structure  	 NN	I-NP
and  	and  	 CC	O
at  	at  	 IN	O
least  	least  	 JJS	O
two  	two  	 CD	O
ligand  	ligand  	 CD	B-NP
binding  	binding  	 JJ	O
sites  	sites  	 NNS	O
present  	present  	 JJ	O
at  	at  	 IN	O
the  	the  	 DT	O
subunit  	subunit  	 JJ	B-NP
interfaces  	interfaces  	 NNS	I-NP
[  	[  	 -LRB-	O
1  	1  	 CD	O
2  	2  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
receptor  	receptor  	 NN	B-NP
family  	family  	 NN	I-NP
is  	is  	 VBZ	O
characterized  	characterized  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
critical  	critical  	 JJ	B-NP
disulfide  	disulfide  	 JJ	I-NP
loop  	loop  	 JJ	I-NP
structure  	structure  	 NN	I-NP
within  	within  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
and  	and  	 CC	O
an  	an  	 DT	O
integral  	integral  	 JJ	B-NP
ion  	ion  	 JJ	I-NP
selective  	selective  	 JJ	I-NP
channel 	channel 	 NN	I-NP
.  	.  	 .	O
LGIC  	LGIC  	 NNP	B-NP
receptors  	receptors  	 NNS	I-NP
are  	are  	 VBP	O
found  	found  	 VBN	O
in  	in  	 IN	O
both  	both  	 PDT	O
the  	the  	 DT	O
peripheral  	peripheral  	 JJ	O
and  	and  	 CC	O
central  	central  	 JJ	O
nervous  	nervous  	 JJ	O
systems 	systems 	 NNS	O
.  	.  	 .	O
Members  	Members  	 NNS	O
of  	of  	 IN	O
this  	this  	 DT	O
family  	family  	 NN	O
include  	include  	 VBP	O
the  	the  	 DT	O
acetylcholine  	acetylcholine  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
[  	[  	 -LRB-	O
3  	3  	 CD	O
4  	4  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
γ-amino  	γ-amino  	 JJ	B-NP
butyric  	butyric  	 JJ	I-NP
acid  	acid  	 NN	I-NP
type  	type  	 NN	I-NP
A  	A  	 DT	I-NP
receptor  	receptor  	 NN	O
( 	( 	 -LRB-	O
GABA  	GABA  	 NNP	B-NP
A  	A  	 NNP	O
R 	R 	 NNP	O
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
5  	5  	 LS	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
glycine  	glycine  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
( 	( 	 -LRB-	O
GlyR 	GlyR 	 NNP	B-NP
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
6  	6  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
first  	first  	 JJ	O
subunit  	subunit  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	O
was  	was  	 VBD	O
cloned  	cloned  	 VBN	O
in  	in  	 IN	O
1991  	1991  	 CD	O
[  	[  	 -LRB-	O
7  	7  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
sequence  	sequence  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
subunit  	subunit  	 NN	B-NP
was  	was  	 VBD	O
shown  	shown  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
highly  	highly  	 RB	O
homologous  	homologous  	 VBN	O
to  	to  	 TO	O
LGIC  	LGIC  	 NNP	B-NP
receptors  	receptors  	 NNS	I-NP
and  	and  	 CC	O
thus  	thus  	 RB	O
identified  	identified  	 VBN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
receptor  	receptor  	 NN	I-NP
as  	as  	 IN	O
another  	another  	 DT	O
member  	member  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
superfamily  	superfamily  	 NN	O
[  	[  	 -LRB-	O
7  	7  	 CD	O
8  	8  	 CD	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Similar  	Similar  	 JJ	O
to  	to  	 TO	O
other  	other  	 JJ	O
LGIC  	LGIC  	 NN	B-NP
receptors 	receptors 	 NNS	I-NP
,  	,  	 ,	O
more  	more  	 JJR	O
than  	than  	 IN	O
one  	one  	 CD	O
subtype  	subtype  	 NN	B-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
identified 	identified 	 VBN	O
.  	.  	 .	O
Two  	Two  	 CD	O
splice  	splice  	 JJ	O
variants  	variants  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
A  	A  	 DT	O
subunit  	subunit  	 NN	B-NP
( 	( 	 -LRB-	O
long  	long  	 JJ	O
and  	and  	 CC	O
short  	short  	 JJ	O
forms 	forms 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
single  	single  	 JJ	O
B  	B  	 NN	B-NP
subunit  	subunit  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
cloned  	cloned  	 NNS	O
[  	[  	 -LRB-	O
10  	10  	 CD	O
11  	11  	 CD	O
12  	12  	 CD	O
13  	13  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Both  	Both  	 PDT	O
the  	the  	 DT	O
long  	long  	 JJ	O
and  	and  	 CC	O
short  	short  	 JJ	O
forms  	forms  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
A  	A  	 NN	O
subunit  	subunit  	 NNS	B-NP
are  	are  	 VBP	O
capable  	capable  	 JJ	O
of  	of  	 IN	O
forming  	forming  	 FW	O
functional  	functional  	 FW	B-NP
homomeric  	homomeric  	 FW	I-NP
receptors  	receptors  	 FW	I-NP
[ 	[ 	 -LRB-	O
5-HT  	5-HT  	 NNP	O
3AL  	3AL  	 NNP	O
R  	R  	 NNP	O
and  	and  	 CC	O
5-HT  	5-HT  	 NNP	O
3AS  	3AS  	 NNP	O
R 	R 	 NNP	O
]  	]  	 -RRB-	O
although  	although  	 IN	O
some  	some  	 DT	O
differences  	differences  	 NNS	O
between  	between  	 IN	O
an  	an  	 DT	O
agonist  	agonist  	 NN	B-NP
and  	and  	 CC	O
partial  	partial  	 JJ	O
agonist  	agonist  	 JJ	B-NP
activity  	activity  	 NN	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
observed  	observed  	 VBN	O
[  	[  	 -LRB-	O
14  	14  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
third  	third  	 JJ	O
subtype  	subtype  	 NN	B-NP
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
combination  	combination  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
A  	A  	 NNP	O
and  	and  	 CC	O
B  	B  	 NNP	O
subunits  	subunits  	 VBD	O
to  	to  	 TO	O
produce  	produce  	 VB	O
a  	a  	 DT	O
heteromeric  	heteromeric  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
of  	of  	 IN	I-NP
unknown  	unknown  	 JJ	I-NP
stoichiometry  	stoichiometry  	 NNS	I-NP
[  	[  	 -LRB-	O
10  	10  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Heteromeric  	Heteromeric  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
are  	are  	 VBP	O
pharmacologically  	pharmacologically  	 VBN	O
and  	and  	 CC	O
functionally  	functionally  	 JJ	O
distinct  	distinct  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
homomeric  	homomeric  	 JJ	O
5-HT  	5-HT  	 NNP	O
3AL  	3AL  	 NNP	O
and  	and  	 CC	O
5-HT  	5-HT  	 CD	O
3AS  	3AS  	 CD	O
receptors  	receptors  	 NNS	O
[  	[  	 -LRB-	O
11  	11  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
Rs  	Rs  	 NNS	B-NP
are  	are  	 VBP	O
distributed  	distributed  	 VBN	O
throughout  	throughout  	 IN	O
the  	the  	 DT	O
central  	central  	 JJ	O
and  	and  	 CC	O
peripheral  	peripheral  	 JJ	O
nervous  	nervous  	 JJ	O
system 	system 	 NN	O
,  	,  	 ,	O
playing  	playing  	 VBG	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
phenomenon  	phenomenon  	 NN	O
such  	such  	 JJ	O
as  	as  	 IN	O
anxiety 	anxiety 	 NN	B-NP
,  	,  	 ,	O
emesis  	emesis  	 NN	B-NP
and  	and  	 CC	O
alcoholism 	alcoholism 	 NN	O
.  	.  	 .	O
Antagonists  	Antagonists  	 NNS	O
to  	to  	 TO	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
Rs  	Rs  	 NNS	B-NP
are  	are  	 VBP	O
clinically  	clinically  	 RB	O
efficacious  	efficacious  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
chemotherapy-induced  	chemotherapy-induced  	 JJ	O
emesis  	emesis  	 NNS	B-NP
[  	[  	 -LRB-	O
15  	15  	 CD	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
recent  	recent  	 JJ	O
studies  	studies  	 NNS	O
on  	on  	 IN	O
human  	human  	 JJ	O
subjects  	subjects  	 NNS	B-NP
have  	have  	 VBP	O
suggested  	suggested  	 VBN	O
their  	their  	 PRP$	O
potential  	potential  	 JJ	B-NP
application  	application  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
early  	early  	 JJ	O
onset  	onset  	 NN	B-NP
alcoholism  	alcoholism  	 NN	I-NP
[  	[  	 -LRB-	O
16  	16  	 CD	O
17  	17  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Hibert  	Hibert  	 FW	O
et  	et  	 FW	O
al  	al  	 FW	O
proposed  	proposed  	 VBN	O
an  	an  	 DT	O
early  	early  	 JJ	O
model  	model  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
antagonist  	antagonist  	 JJ	B-NP
pharmacophore  	pharmacophore  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	O
[  	[  	 -LRB-	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
According  	According  	 VBG	O
to  	to  	 TO	O
this  	this  	 DT	O
model 	model 	 NN	O
,  	,  	 ,	O
all  	all  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
antagonists  	antagonists  	 NNS	I-NP
contain  	contain  	 VBP	O
an  	an  	 DT	O
aromatic  	aromatic  	 JJ	B-NP
ring 	ring 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
carbonyl  	carbonyl  	 JJ	B-NP
oxygen  	oxygen  	 NN	I-NP
or  	or  	 CC	O
bioisosteric  	bioisosteric  	 JJ	B-NP
equivalent 	equivalent 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
basic  	basic  	 JJ	O
nitrogen 	nitrogen 	 NN	B-NP
.  	.  	 .	O
According  	According  	 VBG	O
to  	to  	 TO	O
Hibert 	Hibert 	 NNP	O
's  	's  	 POS	O
model 	model 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
basic  	basic  	 JJ	O
nitrogen  	nitrogen  	 NN	B-NP
is  	is  	 VBZ	O
located  	located  	 VBN	O
5.2A°  	5.2A°  	 CD	O
from  	from  	 IN	O
the  	the  	 DT	O
centre  	centre  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
aromatic  	aromatic  	 JJ	B-NP
ring  	ring  	 NN	I-NP
and  	and  	 CC	O
approximately  	approximately  	 RB	O
1.7A°  	1.7A°  	 CD	O
above  	above  	 IN	O
plane  	plane  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
ring 	ring 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
carbonyl  	carbonyl  	 JJ	B-NP
oxygen  	oxygen  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
aromatic  	aromatic  	 JJ	B-NP
ring  	ring  	 NNS	I-NP
are  	are  	 VBP	O
coplanar  	coplanar  	 VBN	O
and  	and  	 CC	O
separated  	separated  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
distance  	distance  	 NN	O
of  	of  	 IN	O
3.3A° 	3.3A° 	 CD	O
.  	.  	 .	O
Recent  	Recent  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
have  	have  	 VBP	O
expanded  	expanded  	 VBN	O
on  	on  	 IN	O
this  	this  	 DT	O
model  	model  	 NN	O
to  	to  	 TO	O
include  	include  	 VB	O
another  	another  	 DT	O
lipophilic  	lipophilic  	 JJ	B-NP
region  	region  	 NN	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
second  	second  	 JJ	O
hydrogen  	hydrogen  	 NN	B-NP
bonding  	bonding  	 VBD	I-NP
interaction  	interaction  	 CD	I-NP
two  	two  	 CD	O
atoms  	atoms  	 NNS	O
away  	away  	 RB	O
from  	from  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
[  	[  	 -LRB-	O
19  	19  	 CD	O
20  	20  	 CD	O
21  	21  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
compound  	compound  	 NN	B-NP
that  	that  	 WDT	O
contains  	contains  	 VBZ	O
all  	all  	 DT	O
five  	five  	 CD	O
pharmacophoric  	pharmacophoric  	 CD	B-NP
regions  	regions  	 NNS	I-NP
was  	was  	 VBD	O
synthesized  	synthesized  	 VBN	O
by  	by  	 IN	O
Orjales  	Orjales  	 NNP	B-NP
et  	et  	 FW	O
al  	al  	 FW	O
[  	[  	 -LRB-	O
22  	22  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
compound  	compound  	 NN	B-NP
( 	( 	 -LRB-	I-NP
1- 	1- 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
phenylmethyl 	phenylmethyl 	 LS	I-NP
) 	) 	 -RRB-	I-NP
-2-piperizinyl  	-2-piperizinyl  	 CD	I-NP
benzimidazole  	benzimidazole  	 NNS	I-NP
or  	or  	 CC	O
lerisetron 	lerisetron 	 CD	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
figure  	figure  	 NN	O
1and  	1and  	 NN	O
is  	is  	 VBZ	O
a  	a  	 DT	O
potent  	potent  	 JJ	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
antagonist 	antagonist 	 NN	I-NP
.  	.  	 .	O
Functional  	Functional  	 JJ	B-NP
groups  	groups  	 NNS	I-NP
on  	on  	 IN	O
this  	this  	 DT	O
compound  	compound  	 JJ	B-NP
capable  	capable  	 JJ	I-NP
of  	of  	 IN	I-NP
forming  	forming  	 VBG	I-NP
interactions  	interactions  	 NNS	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
are  	are  	 VBP	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
amino  	amino  	 JJ	I-NP
group 	group 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
benzimidazole  	benzimidazole  	 NN	B-NP
and  	and  	 CC	O
a  	a  	 DT	O
benzyl  	benzyl  	 JJ	B-NP
group  	group  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
N1  	N1  	 JJ	B-NP
position  	position  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
benzimidazole 	benzimidazole 	 NN	I-NP
.  	.  	 .	O
While  	While  	 IN	O
Lerisetron  	Lerisetron  	 NNP	B-NP
contains  	contains  	 VBZ	O
no  	no  	 DT	O
carbonyl  	carbonyl  	 JJ	B-NP
group 	group 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
second  	second  	 JJ	O
nitrogen  	nitrogen  	 NNS	B-NP
contained  	contained  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
benzimidazole  	benzimidazole  	 JJ	B-NP
heterocycle  	heterocycle  	 NN	I-NP
could  	could  	 MD	O
act  	act  	 VB	O
as  	as  	 IN	O
bioisostere  	bioisostere  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
functional  	functional  	 JJ	B-NP
group  	group  	 NN	I-NP
[  	[  	 -LRB-	O
22  	22  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Orjales  	Orjales  	 NNP	B-NP
demonstrated  	demonstrated  	 VBD	O
the  	the  	 DT	O
importance  	importance  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	B-NP
group  	group  	 NN	I-NP
by  	by  	 IN	O
synthesizing  	synthesizing  	 JJ	O
several  	several  	 JJ	O
N1  	N1  	 NN	O
substituted  	substituted  	 VBD	O
analogs  	analogs  	 VBN	O
of  	of  	 IN	O
Lerisetron 	Lerisetron 	 NNP	B-NP
.  	.  	 .	O
Removal  	Removal  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	B-NP
group  	group  	 NN	I-NP
produced  	produced  	 VBD	O
a  	a  	 DT	O
80-fold  	80-fold  	 JJ	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
affinity 	affinity 	 NN	B-NP
,  	,  	 ,	O
indicating  	indicating  	 VBG	O
a  	a  	 DT	O
role  	role  	 NN	O
for  	for  	 IN	O
this  	this  	 DT	O
group  	group  	 NN	O
in  	in  	 IN	O
interacting  	interacting  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R.  	R.  	 NNP	O
Other  	Other  	 JJ	O
studies  	studies  	 NNS	O
have  	have  	 VBP	O
supported  	supported  	 VBN	O
this  	this  	 DT	O
observation  	observation  	 NN	O
and  	and  	 CC	O
suggest  	suggest  	 VB	O
a  	a  	 DT	O
more  	more  	 RBR	O
specific  	specific  	 JJ	O
electrostatic  	electrostatic  	 JJ	B-NP
interaction  	interaction  	 NNS	I-NP
[  	[  	 -LRB-	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
While  	While  	 IN	O
structure-activity  	structure-activity  	 JJ	B-NP
relationship  	relationship  	 NN	I-NP
studies  	studies  	 NNS	I-NP
and  	and  	 CC	O
molecular  	molecular  	 JJ	O
modeling  	modeling  	 NNS	O
have  	have  	 VBP	O
led  	led  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
detailed  	detailed  	 JJ	O
pharmacophore  	pharmacophore  	 JJ	B-NP
model 	model 	 NN	I-NP
,  	,  	 ,	O
determining  	determining  	 VBG	O
specific  	specific  	 JJ	O
point  	point  	 NN	B-NP
interactions  	interactions  	 NNS	I-NP
between  	between  	 IN	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
antagonists  	antagonists  	 NNS	O
and  	and  	 CC	O
binding  	binding  	 JJ	O
site  	site  	 NN	B-NP
amino  	amino  	 NN	I-NP
acids  	acids  	 NN	I-NP
has  	has  	 VBZ	O
proven  	proven  	 VBN	O
difficult 	difficult 	 JJ	O
.  	.  	 .	O
Mutagenesis  	Mutagenesis  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
have  	have  	 VBP	O
identified  	identified  	 VBN	O
the  	the  	 DT	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 JJ	I-NP
W89  	W89  	 NN	I-NP
and  	and  	 CC	O
R91  	R91  	 CD	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
ligands  	ligands  	 NNS	I-NP
[  	[  	 -LRB-	O
24  	24  	 CD	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Studies  	Studies  	 NNS	O
conducted  	conducted  	 VBN	O
in  	in  	 IN	O
our  	our  	 PRP$	O
laboratory  	laboratory  	 NN	O
have  	have  	 VBP	O
identified  	identified  	 VBN	O
three  	three  	 CD	O
additional  	additional  	 JJ	O
putative  	putative  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
site  	site  	 NN	I-NP
residues  	residues  	 NNS	I-NP
( 	( 	 -LRB-	O
Y140 	Y140 	 NNP	B-NP
,  	,  	 ,	O
Y142 	Y142 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
Y152 	Y152 	 CD	B-NP
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
25  	25  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
W89  	W89  	 NNP	B-NP
and  	and  	 CC	O
R91  	R91  	 NNP	B-NP
are  	are  	 VBP	O
present  	present  	 JJ	O
in  	in  	 IN	O
a  	a  	 DT	O
conserved  	conserved  	 JJ	O
region  	region  	 NN	O
of  	of  	 IN	O
LGIC  	LGIC  	 NNP	B-NP
receptors  	receptors  	 VBD	O
often  	often  	 RB	O
referred  	referred  	 VBN	O
to  	to  	 TO	O
as  	as  	 RB	O
loop  	loop  	 JJ	O
D  	D  	 NNP	O
[  	[  	 -LRB-	O
24  	24  	 CD	O
26  	26  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Similarly 	Similarly 	 RB	O
,  	,  	 ,	O
Y140 	Y140 	 NNP	B-NP
,  	,  	 ,	O
Y142  	Y142  	 NNP	B-NP
and  	and  	 CC	O
Y152  	Y152  	 NNP	B-NP
are  	are  	 VBP	O
located  	located  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
region  	region  	 NN	B-NP
homologus  	homologus  	 NN	I-NP
to  	to  	 TO	O
E  	E  	 NN	B-NP
loop  	loop  	 NN	I-NP
region  	region  	 NN	I-NP
of  	of  	 IN	I-NP
nicotinic  	nicotinic  	 JJ	I-NP
AchR 	AchR 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
have  	have  	 VBP	O
endeavoured  	endeavoured  	 VBN	O
to  	to  	 TO	O
identify  	identify  	 VB	O
the  	the  	 DT	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 JJ	I-NP
interacting  	interacting  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
different  	different  	 JJ	O
functional  	functional  	 JJ	B-NP
groups  	groups  	 NNS	I-NP
present  	present  	 JJ	O
on  	on  	 IN	O
the  	the  	 DT	O
lerisetron  	lerisetron  	 JJ	B-NP
molecule  	molecule  	 NN	I-NP
in  	in  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
develop  	develop  	 VB	O
a  	a  	 DT	O
model  	model  	 NN	O
for  	for  	 IN	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
compound  	compound  	 NN	B-NP
with  	with  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R.  	R.  	 NNP	O
Using  	Using  	 NNP	O
site  	site  	 NN	O
directed  	directed  	 VBD	O
mutagenesis  	mutagenesis  	 VBN	O
in  	in  	 IN	O
combination  	combination  	 NN	O
with  	with  	 IN	O
analogs  	analogs  	 NN	O
of  	of  	 IN	O
lerisetron 	lerisetron 	 NN	B-NP
,  	,  	 ,	O
we  	we  	 PRP	O
have  	have  	 VBP	O
identified  	identified  	 VBN	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
that  	that  	 WDT	O
appear  	appear  	 VBP	O
to  	to  	 TO	O
interact  	interact  	 VB	O
selectively  	selectively  	 RB	O
with  	with  	 IN	O
the  	the  	 DT	O
terminal  	terminal  	 NN	B-NP
amino  	amino  	 NN	I-NP
group 	group 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	B-NP
group  	group  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
aromatic  	aromatic  	 JJ	B-NP
benzimidazole 	benzimidazole 	 NN	I-NP
.  	.  	 .	O
Results  	Results  	 NNS	O
Functional  	Functional  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
lerisetron  	lerisetron  	 JJ	I-NP
Whole  	Whole  	 JJ	I-NP
cell  	cell  	 NN	I-NP
patch-clamp  	patch-clamp  	 JJ	I-NP
experiments  	experiments  	 NNS	I-NP
were  	were  	 VBD	O
performed  	performed  	 VBN	O
to  	to  	 TO	O
test  	test  	 VB	O
the  	the  	 DT	O
functional  	functional  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
lerisetron 	lerisetron 	 NN	I-NP
.  	.  	 .	O
No  	No  	 DT	O
response  	response  	 NN	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
when  	when  	 WRB	O
lerisetron  	lerisetron  	 NNS	B-NP
was  	was  	 VBD	O
applied  	applied  	 VBN	O
alone  	alone  	 RB	O
( 	( 	 -LRB-	O
data  	data  	 NNS	O
not  	not  	 RB	O
shown 	shown 	 VBN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
When  	When  	 WRB	O
co-applied  	co-applied  	 JJ	O
with  	with  	 IN	O
5-HT 	5-HT 	 NNP	O
,  	,  	 ,	O
lerisetron  	lerisetron  	 NN	B-NP
inhibited  	inhibited  	 VBD	O
the  	the  	 DT	O
absolute  	absolute  	 JJ	B-NP
magnitude  	magnitude  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
response  	response  	 NN	O
with  	with  	 IN	O
no  	no  	 DT	O
apparent  	apparent  	 JJ	O
alteration  	alteration  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
response  	response  	 NN	B-NP
profile  	profile  	 NN	I-NP
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
2 	2 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
combination  	combination  	 NN	O
of  	of  	 IN	O
several  	several  	 JJ	O
identical  	identical  	 JJ	O
inhibition  	inhibition  	 JJ	B-NP
experiments  	experiments  	 NNS	I-NP
produced  	produced  	 VBD	O
a  	a  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
value  	value  	 NN	O
of  	of  	 IN	O
0.2  	0.2  	 CD	O
±  	±  	 CD	O
0.03  	0.03  	 CD	O
nM  	nM  	 NN	B-NP
for  	for  	 IN	I-NP
lerisetron  	lerisetron  	 JJ	I-NP
inhibition  	inhibition  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 JJ	O
induced  	induced  	 JJ	O
response 	response 	 NN	O
.  	.  	 .	O
These  	These  	 DT	O
data  	data  	 NNS	O
correspond  	correspond  	 VBP	O
well  	well  	 RB	O
with  	with  	 IN	O
previously  	previously  	 RB	O
reported  	reported  	 VBN	O
data  	data  	 NNS	O
for  	for  	 IN	O
this  	this  	 DT	O
compound  	compound  	 NN	B-NP
[  	[  	 -LRB-	O
22  	22  	 CD	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
verify  	verify  	 VB	O
the  	the  	 DT	O
competitive  	competitive  	 JJ	B-NP
antagonist  	antagonist  	 JJ	I-NP
action  	action  	 NN	I-NP
of  	of  	 IN	I-NP
lerisetron 	lerisetron 	 NN	I-NP
.  	.  	 .	O
Analogs  	Analogs  	 NNP	O
of  	of  	 IN	O
lerisetron  	lerisetron  	 NNS	B-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
shown  	shown  	 VBN	O
to  	to  	 TO	O
inhibit  	inhibit  	 VB	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
Rs  	Rs  	 NNS	B-NP
in  	in  	 IN	O
a  	a  	 DT	O
similar  	similar  	 JJ	O
manner  	manner  	 NN	O
[  	[  	 -LRB-	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Importance  	Importance  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	O
and  	and  	 CC	O
distal  	distal  	 JJ	O
piperazine  	piperazine  	 JJ	O
nitrogen  	nitrogen  	 NN	O
to  	to  	 TO	O
binding  	binding  	 VB	O
of  	of  	 IN	O
lerisetron  	lerisetron  	 VBG	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
value  	value  	 NN	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 JJ	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
-granisetron  	-granisetron  	 JJ	O
binding  	binding  	 NN	O
to  	to  	 TO	O
wildtype  	wildtype  	 VB	O
receptors  	receptors  	 NNS	O
was  	was  	 VBD	O
determined  	determined  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
0.8  	0.8  	 CD	O
±  	±  	 CD	O
0.19  	0.19  	 CD	O
nM  	nM  	 NNS	O
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
3and  	3and  	 NNP	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
value  	value  	 NN	O
agrees  	agrees  	 VBZ	O
with  	with  	 IN	O
previously  	previously  	 RB	O
published  	published  	 VBN	O
data  	data  	 NNS	O
for  	for  	 IN	O
this  	this  	 DT	O
compound 	compound 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
values  	values  	 NNS	O
for  	for  	 IN	O
analogs  	analogs  	 CD	O
1  	1  	 CD	O
and  	and  	 CC	O
2  	2  	 CD	O
under  	under  	 IN	O
identical  	identical  	 JJ	O
conditions  	conditions  	 NNS	O
are  	are  	 VBP	O
25  	25  	 CD	O
±  	±  	 CD	O
3.2  	3.2  	 CD	O
nM  	nM  	 JJ	O
and  	and  	 CC	O
320  	320  	 CD	O
±  	±  	 CD	O
82  	82  	 CD	O
nM  	nM  	 JJ	O
respectively  	respectively  	 NNS	O
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
4A 	4A 	 NNP	O
,  	,  	 ,	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
observed  	observed  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
represents  	represents  	 VBZ	O
the  	the  	 DT	O
decreases  	decreases  	 NN	O
in  	in  	 IN	O
binding  	binding  	 JJ	O
energy  	energy  	 NN	O
resulting  	resulting  	 VBG	O
from  	from  	 IN	O
removal  	removal  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	O
group  	group  	 NN	O
( 	( 	 -LRB-	O
analog  	analog  	 CD	O
1 	1 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
the  	the  	 DT	O
distal  	distal  	 FW	O
piperazine  	piperazine  	 FW	O
nitrogen  	nitrogen  	 FW	O
( 	( 	 -LRB-	O
analog  	analog  	 CD	O
2 	2 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Identification  	Identification  	 NN	B-NP
of  	of  	 IN	I-NP
amino  	amino  	 JJ	I-NP
acids  	acids  	 JJ	I-NP
interacting  	interacting  	 NN	O
with  	with  	 IN	O
Lerisetron  	Lerisetron  	 NNP	B-NP
In  	In  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
determine  	determine  	 VB	O
the  	the  	 DT	O
nature  	nature  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 JJ	I-NP
interacting  	interacting  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
amino  	amino  	 NN	I-NP
and  	and  	 CC	O
N-benzyl  	N-benzyl  	 JJ	B-NP
groups  	groups  	 NNS	I-NP
of  	of  	 IN	I-NP
lerisetron 	lerisetron 	 NN	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
constructed  	constructed  	 VBD	O
5-HT  	5-HT  	 NNP	O
3AS  	3AS  	 NNP	O
Rs  	Rs  	 NNP	O
containing  	containing  	 VBG	B-NP
mutations  	mutations  	 NNS	I-NP
at  	at  	 IN	O
W89 	W89 	 NNP	B-NP
,  	,  	 ,	O
R91 	R91 	 NNP	B-NP
,  	,  	 ,	O
Y140 	Y140 	 NNP	B-NP
,  	,  	 ,	O
Y142  	Y142  	 NNP	B-NP
and  	and  	 CC	O
Y152 	Y152 	 NNP	B-NP
.  	.  	 .	O
Figure  	Figure  	 NNP	O
3shows  	3shows  	 NNP	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
-granisetron  	-granisetron  	 JJ	O
binding  	binding  	 NN	O
by  	by  	 IN	O
lerisetron  	lerisetron  	 NN	B-NP
on  	on  	 IN	O
wildtype  	wildtype  	 NN	B-NP
and  	and  	 CC	O
mutant  	mutant  	 JJ	B-NP
receptors 	receptors 	 NNS	I-NP
.  	.  	 .	O
For  	For  	 IN	O
most  	most  	 RBS	O
amino  	amino  	 JJ	B-NP
acids 	acids 	 NNS	I-NP
,  	,  	 ,	O
an  	an  	 DT	O
alanine  	alanine  	 JJ	B-NP
substitution  	substitution  	 NN	I-NP
was  	was  	 VBD	O
constructed  	constructed  	 VBN	O
in  	in  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
effectively  	effectively  	 RB	O
remove  	remove  	 VB	O
any  	any  	 DT	O
amino  	amino  	 JJ	B-NP
acid  	acid  	 NN	I-NP
interaction  	interaction  	 NN	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
ligand 	ligand 	 NN	B-NP
.  	.  	 .	O
For  	For  	 IN	O
W89 	W89 	 NNP	B-NP
,  	,  	 ,	O
an  	an  	 DT	O
alanine  	alanine  	 JJ	B-NP
substitution  	substitution  	 NN	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
shown  	shown  	 VBN	O
to  	to  	 TO	O
prevent  	prevent  	 VB	O
binding  	binding  	 VBN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron 	granisetron 	 NN	B-NP
;  	;  	 :	O
therefore  	therefore  	 RB	O
a  	a  	 DT	O
less  	less  	 RBR	O
severe  	severe  	 JJ	O
mutation  	mutation  	 NN	O
was  	was  	 VBD	O
constructed 	constructed 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
W89F  	W89F  	 JJ	O
mutation  	mutation  	 NN	O
produces  	produces  	 VBZ	O
a  	a  	 DT	O
18-fold  	18-fold  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
d  	d  	 NN	O
for  	for  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
-granisetron  	-granisetron  	 JJ	O
binding  	binding  	 NNS	O
( 	( 	 -LRB-	O
18  	18  	 CD	O
±  	±  	 CD	O
2  	2  	 CD	O
nM 	nM 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
the  	the  	 DT	O
W89Y  	W89Y  	 JJ	O
mutation  	mutation  	 NN	O
produces  	produces  	 VBZ	O
a  	a  	 DT	O
5.8-fold  	5.8-fold  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
d  	d  	 NNS	O
( 	( 	 -LRB-	O
5.7  	5.7  	 CD	O
±  	±  	 CD	O
0.7  	0.7  	 CD	O
nM 	nM 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Mutation  	Mutation  	 NN	O
of  	of  	 IN	O
amino  	amino  	 JJ	O
acid  	acid  	 NN	O
R91  	R91  	 NN	O
to  	to  	 TO	O
alanine  	alanine  	 VB	O
produced  	produced  	 VBN	O
a  	a  	 DT	O
5-fold  	5-fold  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
d  	d  	 NN	O
for  	for  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 FW	O
binding  	binding  	 FW	O
( 	( 	 -LRB-	O
4.9  	4.9  	 CD	O
±  	±  	 CD	O
0.7  	0.7  	 CD	O
nM 	nM 	 NN	O
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
data  	data  	 NNS	O
agree  	agree  	 VBP	O
well  	well  	 RB	O
with  	with  	 IN	O
previously  	previously  	 RB	O
reported  	reported  	 VBN	O
values  	values  	 NNS	O
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Alanine  	Alanine  	 JJ	O
mutations  	mutations  	 NNS	O
at  	at  	 IN	O
the  	the  	 DT	O
tyrosine  	tyrosine  	 JJ	O
positions  	positions  	 NNS	O
Y140 	Y140 	 RB	O
,  	,  	 ,	O
Y142  	Y142  	 NNP	O
and  	and  	 CC	O
Y152  	Y152  	 NNP	O
also  	also  	 RB	O
produced  	produced  	 VBN	O
minor  	minor  	 JJ	O
increases  	increases  	 NNS	O
in  	in  	 IN	O
K  	K  	 NNP	O
d  	d  	 NN	O
for  	for  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 FW	O
binding  	binding  	 FW	O
( 	( 	 -LRB-	O
2.7  	2.7  	 CD	O
±  	±  	 CD	O
0.19  	0.19  	 CD	O
nM 	nM 	 NN	O
,  	,  	 ,	O
4.5  	4.5  	 CD	O
±  	±  	 CD	O
0.5  	0.5  	 CD	O
nM  	nM  	 JJ	O
and  	and  	 CC	O
7.8  	7.8  	 CD	O
±  	±  	 CD	O
1.1  	1.1  	 CD	O
nM  	nM  	 JJ	O
respectively 	respectively 	 NN	O
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
25  	25  	 CD	O
]  	]  	 -RRB-	O
( 	( 	 -LRB-	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Only  	Only  	 RB	O
small  	small  	 JJ	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 NN	O
were  	were  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
Y140A  	Y140A  	 JJ	O
mutation  	mutation  	 NN	O
while  	while  	 IN	O
the  	the  	 DT	O
Y142A  	Y142A  	 NNP	O
and  	and  	 CC	O
Y152A  	Y152A  	 CD	O
mutations  	mutations  	 NNS	O
produced  	produced  	 VBD	O
large  	large  	 JJ	O
increases  	increases  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
( 	( 	 -LRB-	O
Table  	Table  	 NNP	O
1and  	1and  	 NNP	O
Figure  	Figure  	 NNP	O
3 	3 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
For  	For  	 IN	O
W89F  	W89F  	 NNP	O
and  	and  	 CC	O
W89Y 	W89Y 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 NN	O
were  	were  	 VBD	O
much  	much  	 RB	O
smaller  	smaller  	 JJR	O
than  	than  	 IN	O
for  	for  	 IN	O
the  	the  	 DT	O
alanine  	alanine  	 JJ	O
mutations  	mutations  	 NNS	O
at  	at  	 IN	O
Y142A  	Y142A  	 NNP	O
and  	and  	 CC	O
Y152A 	Y152A 	 NNP	O
,  	,  	 ,	O
as  	as  	 RB	O
would  	would  	 MD	O
be  	be  	 VB	O
expected  	expected  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
less  	less  	 RBR	O
severe  	severe  	 JJ	O
nature  	nature  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
mutations 	mutations 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
changes  	changes  	 NNS	O
were 	were 	 VBD	O
,  	,  	 ,	O
however  	however  	 RB	O
significant  	significant  	 JJ	O
( 	( 	 -LRB-	O
p  	p  	 JJ	O
< 	< 	 SYM	O
0.001  	0.001  	 NN	O
in  	in  	 IN	O
both  	both  	 DT	O
cases 	cases 	 NNS	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
are  	are  	 VBP	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
K  	K  	 NNP	O
d  	d  	 VBD	O
reported  	reported  	 VBN	O
for  	for  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron 	granisetron 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
W89F  	W89F  	 JJ	O
mutant  	mutant  	 JJ	O
receptor  	receptor  	 NN	O
was  	was  	 VBD	O
4.8  	4.8  	 CD	O
±  	±  	 CD	O
0.56  	0.56  	 CD	O
fold  	fold  	 NNS	O
and  	and  	 CC	O
the  	the  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
W89Y  	W89Y  	 JJ	O
receptor  	receptor  	 NN	O
was  	was  	 VBD	O
3.6  	3.6  	 CD	O
±  	±  	 CD	O
0.4  	0.4  	 CD	O
fold 	fold 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
R91A  	R91A  	 CD	O
mutant  	mutant  	 NNS	O
produced  	produced  	 VBD	O
an  	an  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
of  	of  	 IN	O
7.6  	7.6  	 CD	O
±  	±  	 CD	O
1.5  	1.5  	 CD	O
fold  	fold  	 NNS	O
as  	as  	 RB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
wildtype  	wildtype  	 JJ	O
receptor 	receptor 	 NN	O
.  	.  	 .	O
These  	These  	 DT	O
data  	data  	 NNS	O
indicated  	indicated  	 VBD	O
potential  	potential  	 JJ	O
interactions  	interactions  	 NNS	O
of  	of  	 IN	O
lerisetron  	lerisetron  	 NN	O
with  	with  	 IN	O
W89 	W89 	 NNP	O
,  	,  	 ,	O
R91 	R91 	 NNP	O
,  	,  	 ,	O
Y142  	Y142  	 NNP	O
and  	and  	 CC	O
Y152 	Y152 	 NNP	O
.  	.  	 .	O
Mutation  	Mutation  	 NN	O
of  	of  	 IN	O
W89  	W89  	 CD	O
As  	As  	 IN	O
mentioned  	mentioned  	 VBN	O
above 	above 	 IN	O
,  	,  	 ,	O
the  	the  	 DT	O
lack  	lack  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
-granisetron  	-granisetron  	 JJ	O
binding  	binding  	 NN	O
to  	to  	 TO	O
W89A  	W89A  	 CD	O
mutant  	mutant  	 CD	O
receptors  	receptors  	 NNS	O
necessitated  	necessitated  	 VBD	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
W89F  	W89F  	 NNP	O
and  	and  	 CC	O
W89Y  	W89Y  	 CD	O
mutations  	mutations  	 NNS	O
to  	to  	 TO	O
analyze  	analyze  	 VB	O
functional  	functional  	 JJ	O
group  	group  	 NN	O
interactions 	interactions 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
these  	these  	 DT	O
mutations  	mutations  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
analogs  	analogs  	 CD	O
1  	1  	 CD	O
and  	and  	 CC	O
2  	2  	 CD	O
are  	are  	 VBP	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
figure  	figure  	 NN	O
4B 	4B 	 NN	O
,  	,  	 ,	O
4Cand  	4Cand  	 NNP	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
.  	.  	 .	O
Analog  	Analog  	 NNP	O
1  	1  	 CD	O
inhibited  	inhibited  	 NNS	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
-granisetron  	-granisetron  	 JJ	O
binding  	binding  	 NN	O
to  	to  	 TO	O
W89F  	W89F  	 CD	O
receptors  	receptors  	 NNS	O
with  	with  	 IN	O
a  	a  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
of  	of  	 IN	O
170  	170  	 CD	O
±  	±  	 CD	O
54  	54  	 CD	O
nM  	nM  	 NNS	O
( 	( 	 -LRB-	O
7  	7  	 CD	O
±  	±  	 CD	O
3.2  	3.2  	 CD	O
fold  	fold  	 JJ	O
increase 	increase 	 NN	O
,  	,  	 ,	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.001 	0.001 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
W89Y  	W89Y  	 CD	O
receptors  	receptors  	 NNS	O
with  	with  	 IN	O
a  	a  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
of  	of  	 IN	O
81  	81  	 CD	O
±  	±  	 CD	O
14  	14  	 CD	O
nM  	nM  	 NNS	O
( 	( 	 -LRB-	O
3.2  	3.2  	 CD	O
±  	±  	 CD	O
0.6  	0.6  	 CD	O
fold  	fold  	 JJ	O
increase 	increase 	 NN	O
,  	,  	 ,	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.001 	0.001 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
reflects  	reflects  	 VBZ	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
and  	and  	 CC	O
reflects  	reflects  	 VBZ	O
a  	a  	 DT	O
potential  	potential  	 JJ	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
analog  	analog  	 CD	O
1  	1  	 CD	O
with  	with  	 IN	O
W89 	W89 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
strength  	strength  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
interaction  	interaction  	 NN	O
is  	is  	 VBZ	O
apparently  	apparently  	 RB	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
strength  	strength  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
-granisetron  	-granisetron  	 JJ	O
and  	and  	 CC	O
lerisetron  	lerisetron  	 NN	O
since  	since  	 IN	O
the  	the  	 DT	O
magnitude  	magnitude  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
change  	change  	 NN	O
is  	is  	 VBZ	O
similar  	similar  	 JJ	O
in  	in  	 IN	O
both  	both  	 DT	O
cases 	cases 	 NNS	O
.  	.  	 .	O
Analog  	Analog  	 NNP	O
2  	2  	 CD	O
also  	also  	 RB	O
showed  	showed  	 VBD	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
W89F  	W89F  	 NNP	O
and  	and  	 CC	O
W89Y  	W89Y  	 CD	O
mutations 	mutations 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
magnitude  	magnitude  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
change  	change  	 NN	O
for  	for  	 IN	O
W89F  	W89F  	 NNP	O
( 	( 	 -LRB-	O
5.1  	5.1  	 CD	O
±  	±  	 CD	O
1.3  	1.3  	 CD	O
fold 	fold 	 NN	O
,  	,  	 ,	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
was  	was  	 VBD	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
that  	that  	 WDT	O
observed  	observed  	 VBD	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 NN	O
and  	and  	 CC	O
analog  	analog  	 CD	O
1 	1 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
W89Y  	W89Y  	 JJ	O
mutation  	mutation  	 NN	O
produced  	produced  	 VBD	O
a  	a  	 DT	O
6.8  	6.8  	 CD	O
±  	±  	 CD	O
1.6  	1.6  	 CD	O
fold  	fold  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
all  	all  	 DT	O
three  	three  	 CD	O
compounds  	compounds  	 NNS	O
appear  	appear  	 VBP	O
to  	to  	 TO	O
form  	form  	 VB	O
similar  	similar  	 JJ	O
interactions  	interactions  	 NNS	O
with  	with  	 IN	O
W89 	W89 	 CD	O
.  	.  	 .	O
Mutation  	Mutation  	 NN	O
of  	of  	 IN	O
R91  	R91  	 NNP	O
Mutation  	Mutation  	 NNP	O
of  	of  	 IN	O
R91  	R91  	 CD	O
to  	to  	 TO	B-NP
alanine  	alanine  	 VB	I-NP
( 	( 	 -LRB-	O
R91A 	R91A 	 NNP	B-NP
)  	)  	 -RRB-	O
resulted  	resulted  	 VBD	O
in  	in  	 IN	O
a  	a  	 DT	O
significant 	significant 	 JJ	O
,  	,  	 ,	O
but  	but  	 CC	O
small  	small  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 NN	O
of  	of  	 IN	O
7.6  	7.6  	 CD	O
±  	±  	 CD	O
1.5  	1.5  	 CD	O
fold  	fold  	 NNS	O
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.01 	0.01 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Figure  	Figure  	 NN	O
4Dshows  	4Dshows  	 VBZ	O
the  	the  	 DT	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
-granisetron  	-granisetron  	 JJ	O
binding  	binding  	 NN	O
by  	by  	 IN	O
analogs  	analogs  	 CD	O
1  	1  	 CD	O
and  	and  	 CC	O
2  	2  	 CD	O
at  	at  	 IN	O
R91A  	R91A  	 CD	O
mutant  	mutant  	 CD	O
receptors 	receptors 	 NNS	O
.  	.  	 .	O
No  	No  	 DT	O
significant  	significant  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
on  	on  	 IN	O
these  	these  	 DT	O
receptors  	receptors  	 NN	O
for  	for  	 IN	O
either  	either  	 DT	O
analog  	analog  	 JJ	O
1  	1  	 CD	O
( 	( 	 -LRB-	O
0.9  	0.9  	 CD	O
±  	±  	 CD	O
0.28  	0.28  	 CD	O
fold 	fold 	 CD	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
analog  	analog  	 CD	O
2  	2  	 CD	O
( 	( 	 -LRB-	O
0.56  	0.56  	 CD	O
±  	±  	 CD	O
0.14  	0.14  	 CD	O
fold 	fold 	 CD	O
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
)  	)  	 -RRB-	O
as  	as  	 RB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
wildtype  	wildtype  	 JJ	O
receptor 	receptor 	 NN	O
.  	.  	 .	O
Mutation  	Mutation  	 NN	O
of  	of  	 IN	O
Y142  	Y142  	 NNP	O
Mutation  	Mutation  	 NNP	O
of  	of  	 IN	O
Y142  	Y142  	 CD	O
to  	to  	 TO	O
alanine  	alanine  	 VB	O
produced  	produced  	 VBN	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
largest  	largest  	 JJS	O
observed  	observed  	 JJ	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 NNS	O
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
3and  	3and  	 NNP	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 VBD	O
obtained  	obtained  	 VBN	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 NN	O
was  	was  	 VBD	O
130  	130  	 CD	O
±  	±  	 CD	O
28  	28  	 CD	O
nM 	nM 	 NN	O
,  	,  	 ,	O
reflecting  	reflecting  	 VBG	O
a  	a  	 DT	O
change  	change  	 NN	O
of  	of  	 IN	O
160  	160  	 CD	O
±  	±  	 CD	O
37  	37  	 CD	O
fold  	fold  	 NNS	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
wildtype  	wildtype  	 VB	O
receptors 	receptors 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
value  	value  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
1 	1 	 CD	O
,  	,  	 ,	O
in  	in  	 IN	O
contrast 	contrast 	 NN	O
,  	,  	 ,	O
increased  	increased  	 VBD	O
only  	only  	 RB	O
6.8  	6.8  	 CD	O
±  	±  	 CD	O
2.3  	2.3  	 CD	O
fold  	fold  	 NNS	O
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.01 	0.01 	 CD	O
)  	)  	 -RRB-	O
as  	as  	 IN	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
mutation  	mutation  	 NN	O
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
4Eand  	4Eand  	 NNP	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
showed  	showed  	 VBD	O
a  	a  	 DT	O
similar  	similar  	 JJ	O
change  	change  	 NN	O
of  	of  	 IN	O
17  	17  	 CD	O
±  	±  	 CD	O
0.77  	0.77  	 CD	O
fold  	fold  	 NNS	O
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.01 	0.01 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
While  	While  	 IN	O
these  	these  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
values  	values  	 NNS	O
are  	are  	 VBP	O
significantly  	significantly  	 RB	O
different  	different  	 JJ	O
from  	from  	 IN	O
wildtype  	wildtype  	 JJ	O
values  	values  	 NNS	O
for  	for  	 IN	O
each  	each  	 DT	O
analog 	analog 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
lack  	lack  	 NN	O
of  	of  	 IN	O
larger  	larger  	 JJR	O
effects  	effects  	 NNS	O
suggests  	suggests  	 VBZ	O
that  	that  	 IN	O
neither  	neither  	 DT	O
analog  	analog  	 JJ	O
1  	1  	 CD	O
nor  	nor  	 CC	O
analog  	analog  	 CD	O
2  	2  	 CD	O
bind  	bind  	 NN	O
as  	as  	 IN	O
strongly  	strongly  	 RB	O
as  	as  	 IN	O
lerisetron  	lerisetron  	 VBG	O
to  	to  	 TO	O
Y142 	Y142 	 CD	O
.  	.  	 .	O
Mutation  	Mutation  	 NN	O
of  	of  	 IN	O
Y152  	Y152  	 CD	O
The  	The  	 DT	O
Y152A  	Y152A  	 JJ	O
mutation  	mutation  	 NN	O
showed  	showed  	 VBD	O
the  	the  	 DT	O
most  	most  	 RBS	O
variability  	variability  	 JJ	O
in  	in  	 IN	O
its  	its  	 PRP$	O
effects  	effects  	 NNS	O
on  	on  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
values  	values  	 NNS	O
for  	for  	 IN	O
lerisetron 	lerisetron 	 NN	O
,  	,  	 ,	O
analog  	analog  	 CD	O
1  	1  	 CD	O
and  	and  	 CC	O
analog  	analog  	 CD	O
2  	2  	 CD	O
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
3 	3 	 CD	O
,  	,  	 ,	O
Figure  	Figure  	 NNP	O
4Fand  	4Fand  	 NNP	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Lerisetron  	Lerisetron  	 JJ	O
inhibited  	inhibited  	 NNS	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
-granisetron  	-granisetron  	 JJ	O
binding  	binding  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
value  	value  	 NN	O
of  	of  	 IN	O
150  	150  	 CD	O
±  	±  	 CD	O
36 	36 	 CD	O
;  	;  	 :	O
an  	an  	 DT	O
increase  	increase  	 NN	O
of  	of  	 IN	O
190  	190  	 CD	O
±  	±  	 CD	O
43  	43  	 CD	O
fold  	fold  	 NNS	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
wildtype  	wildtype  	 VB	O
values 	values 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
value  	value  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
1  	1  	 CD	O
increased  	increased  	 VBN	O
from  	from  	 IN	O
25  	25  	 CD	O
±  	±  	 CD	O
3.2  	3.2  	 CD	O
nM  	nM  	 NNS	O
( 	( 	 -LRB-	O
wildtype 	wildtype 	 LS	O
)  	)  	 -RRB-	O
to  	to  	 TO	O
2.5  	2.5  	 CD	O
±  	±  	 CD	O
0.40  	0.40  	 CD	O
μM 	μM 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
change  	change  	 NN	O
of  	of  	 IN	O
100  	100  	 CD	O
±  	±  	 CD	O
16  	16  	 CD	O
fold  	fold  	 NN	O
is  	is  	 VBZ	O
slightly  	slightly  	 RB	O
smaller 	smaller 	 JJR	O
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
significantly  	significantly  	 RB	O
different  	different  	 JJ	O
from  	from  	 IN	O
the  	the  	 DT	O
relative  	relative  	 JJ	O
change  	change  	 NN	O
observed  	observed  	 VBD	O
for  	for  	 IN	O
lerisetron 	lerisetron 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
increased  	increased  	 VBN	O
from  	from  	 IN	O
0.32  	0.32  	 CD	O
±  	±  	 CD	O
0.08  	0.08  	 CD	O
μM  	μM  	 NN	O
on  	on  	 IN	O
wildtype  	wildtype  	 VBG	O
to  	to  	 TO	O
13  	13  	 CD	O
±  	±  	 CD	O
4.2  	4.2  	 CD	O
μM  	μM  	 NN	O
on  	on  	 IN	O
Y152A  	Y152A  	 FW	O
mutant  	mutant  	 FW	O
receptors  	receptors  	 FW	O
( 	( 	 -LRB-	O
40  	40  	 CD	O
±  	±  	 CD	O
12  	12  	 CD	O
fold  	fold  	 JJ	O
increase 	increase 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
increase  	increase  	 NN	O
observed  	observed  	 VBD	O
for  	for  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
less  	less  	 JJR	O
than  	than  	 IN	O
that  	that  	 WDT	O
observed  	observed  	 VBD	O
for  	for  	 IN	O
both  	both  	 DT	O
lerisetron  	lerisetron  	 NN	O
and  	and  	 CC	O
analog  	analog  	 CD	O
1 	1 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
smaller  	smaller  	 JJR	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
suggests  	suggests  	 VBZ	O
that  	that  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
binds  	binds  	 JJ	O
weakly  	weakly  	 NN	O
to  	to  	 TO	O
Y152  	Y152  	 CD	O
while  	while  	 IN	O
lerisetron  	lerisetron  	 NN	O
and  	and  	 CC	O
analog  	analog  	 CD	O
1  	1  	 CD	O
bind  	bind  	 NN	O
more  	more  	 RBR	O
tightly 	tightly 	 RB	O
.  	.  	 .	O
Discussion  	Discussion  	 NNP	O
Functional  	Functional  	 NNP	O
group  	group  	 NN	O
interactions  	interactions  	 NNS	O
of  	of  	 IN	O
W89  	W89  	 CD	O
The  	The  	 DT	O
W89F  	W89F  	 JJ	O
mutation  	mutation  	 NN	O
produced  	produced  	 VBD	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
all  	all  	 DT	O
three  	three  	 CD	O
compounds 	compounds 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
magnitude  	magnitude  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
change  	change  	 NN	O
was  	was  	 VBD	O
similar  	similar  	 JJ	O
in  	in  	 IN	O
all  	all  	 DT	O
cases 	cases 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
was  	was  	 VBD	O
identical  	identical  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
d  	d  	 NN	O
that  	that  	 WDT	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 JJ	O
binding  	binding  	 NN	O
on  	on  	 IN	O
this  	this  	 DT	O
mutant  	mutant  	 NN	O
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Alterations  	Alterations  	 NNP	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 VBZ	O
resulting  	resulting  	 VBG	O
from  	from  	 IN	O
the  	the  	 DT	O
W89Y  	W89Y  	 JJ	O
mutation  	mutation  	 NN	O
were  	were  	 VBD	O
slightly  	slightly  	 RB	O
less 	less 	 RBR	O
,  	,  	 ,	O
however  	however  	 RB	O
the  	the  	 DT	O
change  	change  	 NN	O
was  	was  	 VBD	O
again  	again  	 RB	O
the  	the  	 DT	O
same  	same  	 JJ	O
for  	for  	 IN	O
lerisetron 	lerisetron 	 NN	B-NP
,  	,  	 ,	O
analog  	analog  	 CD	O
1  	1  	 CD	O
and  	and  	 CC	O
analog  	analog  	 CD	O
2 	2 	 CD	O
.  	.  	 .	O
These  	These  	 DT	O
data  	data  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
all  	all  	 DT	O
three  	three  	 CD	O
compounds  	compounds  	 NNS	O
form  	form  	 VBP	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
interactions  	interactions  	 NNS	O
with  	with  	 IN	O
W89 	W89 	 CD	B-NP
.  	.  	 .	O
The  	The  	 DT	O
interaction  	interaction  	 NN	O
between  	between  	 IN	O
lerisetron  	lerisetron  	 NN	B-NP
and  	and  	 CC	O
W89  	W89  	 NNP	B-NP
is  	is  	 VBZ	O
unlikely  	unlikely  	 JJ	O
to  	to  	 TO	O
be  	be  	 VB	O
via  	via  	 IN	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	B-NP
functional  	functional  	 JJ	I-NP
group  	group  	 NN	I-NP
since  	since  	 IN	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
1  	1  	 CD	O
was  	was  	 VBD	O
also  	also  	 RB	O
altered  	altered  	 VBN	O
by  	by  	 IN	O
this  	this  	 DT	O
mutation 	mutation 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
same  	same  	 JJ	O
argument  	argument  	 NN	O
can  	can  	 MD	O
be  	be  	 VB	O
made  	made  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
piperazine  	piperazine  	 JJ	I-NP
nitrogen  	nitrogen  	 NN	I-NP
since  	since  	 IN	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
also  	also  	 RB	O
increased 	increased 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
portion  	portion  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
molecule  	molecule  	 JJ	B-NP
common  	common  	 JJ	I-NP
to  	to  	 TO	O
all  	all  	 DT	O
three  	three  	 CD	O
compounds 	compounds 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
aromatic  	aromatic  	 JJ	B-NP
benzimidazole 	benzimidazole 	 NN	I-NP
,  	,  	 ,	O
is  	is  	 VBZ	O
thus  	thus  	 RB	O
the  	the  	 DT	O
most  	most  	 RBS	O
likely  	likely  	 JJ	O
point  	point  	 NN	O
of  	of  	 IN	O
interaction  	interaction  	 NN	O
for  	for  	 IN	O
W89 	W89 	 CD	B-NP
.  	.  	 .	O
Functional  	Functional  	 JJ	O
group  	group  	 NN	O
interactions  	interactions  	 NNS	O
of  	of  	 IN	O
R91  	R91  	 CD	O
The  	The  	 DT	O
R91A  	R91A  	 JJ	O
mutation  	mutation  	 NN	O
increased  	increased  	 VBD	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
value  	value  	 NN	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 JJ	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 JJ	O
binding  	binding  	 NN	O
by  	by  	 IN	O
7.6  	7.6  	 CD	O
fold 	fold 	 NNS	O
.  	.  	 .	O
This  	This  	 DT	O
is  	is  	 VBZ	O
a  	a  	 DT	O
moderately  	moderately  	 RB	O
small  	small  	 JJ	O
change  	change  	 NN	O
for  	for  	 IN	O
an  	an  	 DT	O
alanine  	alanine  	 JJ	O
mutation 	mutation 	 NN	O
,  	,  	 ,	O
particularly  	particularly  	 RB	O
considering  	considering  	 VBG	O
that  	that  	 IN	O
the  	the  	 DT	O
smallest  	smallest  	 JJS	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
removal  	removal  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
functional  	functional  	 JJ	O
group  	group  	 NN	O
on  	on  	 IN	O
lerisetron  	lerisetron  	 NNS	O
( 	( 	 -LRB-	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	O
group 	group 	 NN	O
)  	)  	 -RRB-	O
was  	was  	 VBD	O
31  	31  	 CD	O
fold 	fold 	 NNS	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
therefore  	therefore  	 RB	O
likely  	likely  	 JJ	O
that  	that  	 IN	O
this  	this  	 DT	O
interaction  	interaction  	 NN	O
is  	is  	 VBZ	O
either  	either  	 RB	O
extremely  	extremely  	 RB	O
weak  	weak  	 JJ	O
or  	or  	 CC	O
the  	the  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
is  	is  	 VBZ	O
the  	the  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
structural  	structural  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site 	site 	 NN	O
.  	.  	 .	O
Previous  	Previous  	 JJ	O
studies  	studies  	 NNS	O
concluded  	concluded  	 VBD	O
that  	that  	 IN	O
R91  	R91  	 NNP	O
was  	was  	 VBD	O
an  	an  	 DT	O
important  	important  	 JJ	O
interaction  	interaction  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	O
agonist  	agonist  	 VBD	O
5-hydroxytryptamine  	5-hydroxytryptamine  	 CD	B-NP
( 	( 	 -LRB-	O
5-HT 	5-HT 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
since  	since  	 IN	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
5-HT  	5-HT  	 NNP	O
inhibition  	inhibition  	 VBD	O
increased  	increased  	 VBN	O
over  	over  	 IN	O
3000  	3000  	 CD	O
fold  	fold  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
R91A  	R91A  	 JJ	O
mutation  	mutation  	 NN	O
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
d  	d  	 NN	O
for  	for  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 VBP	O
binding  	binding  	 VBG	O
to  	to  	 TO	O
R91A  	R91A  	 NNP	O
was  	was  	 VBD	O
also  	also  	 RB	O
observed 	observed 	 VBD	O
.  	.  	 .	O
In  	In  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
determine  	determine  	 VB	O
whether  	whether  	 IN	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	O
or  	or  	 CC	O
distal  	distal  	 JJ	O
piperazine  	piperazine  	 JJ	O
nitrogen  	nitrogen  	 NN	O
of  	of  	 IN	O
lerisetron  	lerisetron  	 NN	O
was  	was  	 VBD	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
an  	an  	 DT	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
R91 	R91 	 NNP	O
,  	,  	 ,	O
we  	we  	 PRP	O
tested  	tested  	 VBD	O
both  	both  	 DT	O
analog  	analog  	 JJ	O
1  	1  	 CD	O
and  	and  	 CC	O
2  	2  	 CD	O
on  	on  	 IN	O
R91A  	R91A  	 CD	O
mutant  	mutant  	 CD	O
receptors 	receptors 	 NNS	O
.  	.  	 .	O
No  	No  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
either  	either  	 DT	O
compound 	compound 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
result  	result  	 NN	O
makes  	makes  	 VBZ	O
it  	it  	 PRP	O
much  	much  	 RB	O
more  	more  	 RBR	O
difficult  	difficult  	 JJ	O
to  	to  	 TO	O
assign  	assign  	 VB	O
the  	the  	 DT	O
correct  	correct  	 JJ	O
functional  	functional  	 JJ	B-NP
group  	group  	 NN	I-NP
to  	to  	 TO	O
this  	this  	 DT	O
amino  	amino  	 JJ	B-NP
acid  	acid  	 NN	I-NP
since  	since  	 IN	O
it  	it  	 PRP	O
suggests  	suggests  	 VBZ	O
that  	that  	 IN	O
one  	one  	 CD	O
or  	or  	 CC	O
both  	both  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
compounds  	compounds  	 NN	O
is  	is  	 VBZ	O
no  	no  	 RB	O
longer  	longer  	 RB	O
binding  	binding  	 VBG	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
in  	in  	 IN	O
precisely  	precisely  	 RB	O
the  	the  	 DT	O
same  	same  	 JJ	O
manner  	manner  	 NN	O
as  	as  	 IN	O
lerisetron 	lerisetron 	 NN	B-NP
.  	.  	 .	O
Considering  	Considering  	 VBG	O
the  	the  	 DT	O
small  	small  	 JJ	O
change  	change  	 NN	O
observed  	observed  	 VBD	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 JJ	B-NP
binding  	binding  	 NN	I-NP
as  	as  	 IN	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
mutation 	mutation 	 NN	O
,  	,  	 ,	O
even  	even  	 RB	O
a  	a  	 DT	O
slight  	slight  	 JJ	O
reorientation  	reorientation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
molecule  	molecule  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
could  	could  	 MD	O
result  	result  	 VB	O
in  	in  	 IN	O
the  	the  	 DT	O
loss  	loss  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
interaction 	interaction 	 NN	O
.  	.  	 .	O
Functional  	Functional  	 JJ	O
group  	group  	 NN	O
interactions  	interactions  	 NNS	O
of  	of  	 IN	O
Y142  	Y142  	 CD	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
values  	values  	 NNS	O
for  	for  	 IN	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 JJ	O
binding  	binding  	 NN	O
by  	by  	 IN	O
analogs  	analogs  	 CD	O
1  	1  	 CD	O
and  	and  	 CC	O
2  	2  	 CD	O
were  	were  	 VBD	O
altered  	altered  	 VBN	O
only  	only  	 RB	O
slightly  	slightly  	 RB	O
by  	by  	 IN	O
the  	the  	 DT	O
Y142A  	Y142A  	 JJ	O
mutation 	mutation 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
magnitude  	magnitude  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
lerisetron 	lerisetron 	 NN	O
,  	,  	 ,	O
however 	however 	 RB	O
,  	,  	 ,	O
was  	was  	 VBD	O
considerably  	considerably  	 RB	O
larger  	larger  	 JJR	O
( 	( 	 -LRB-	O
160  	160  	 CD	O
fold 	fold 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
is  	is  	 VBZ	O
indicative  	indicative  	 VBN	O
of  	of  	 IN	O
an  	an  	 DT	O
important  	important  	 JJ	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
compound  	compound  	 NN	O
with  	with  	 IN	O
Y142 	Y142 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
lack  	lack  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
large  	large  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
both  	both  	 DT	O
analogs  	analogs  	 NN	O
makes  	makes  	 VBZ	O
it  	it  	 PRP	O
difficult  	difficult  	 JJ	O
to  	to  	 TO	O
interpret  	interpret  	 VB	O
this  	this  	 DT	O
data  	data  	 NNS	O
since  	since  	 IN	O
one  	one  	 CD	O
or  	or  	 CC	O
both  	both  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
compounds  	compounds  	 NN	O
appears  	appears  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
interacting  	interacting  	 VBN	O
differently  	differently  	 RB	O
with  	with  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
than  	than  	 IN	O
lerisetron 	lerisetron 	 NN	O
.  	.  	 .	O
Analogs  	Analogs  	 NNP	O
1  	1  	 CD	O
and  	and  	 CC	O
2  	2  	 CD	O
differ  	differ  	 NN	O
from  	from  	 IN	O
each  	each  	 DT	O
other  	other  	 JJ	O
both  	both  	 CC	O
in  	in  	 IN	O
the  	the  	 DT	O
functional  	functional  	 JJ	B-NP
groups  	groups  	 NNS	I-NP
contained  	contained  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
molecule  	molecule  	 NN	B-NP
and  	and  	 CC	O
their  	their  	 PRP$	O
structural  	structural  	 JJ	B-NP
similarity  	similarity  	 NN	I-NP
to  	to  	 TO	O
lerisetron 	lerisetron 	 VB	O
.  	.  	 .	O
Analog  	Analog  	 NNP	O
2  	2  	 CD	O
is  	is  	 VBZ	O
most  	most  	 RBS	O
similar  	similar  	 JJ	O
in  	in  	 IN	O
overall  	overall  	 JJ	O
structure 	structure 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
substitution  	substitution  	 NN	B-NP
of  	of  	 IN	I-NP
oxygen  	oxygen  	 NN	I-NP
for  	for  	 IN	I-NP
the  	the  	 DT	I-NP
distal  	distal  	 JJ	I-NP
amino  	amino  	 NNS	I-NP
nitrogen  	nitrogen  	 VBP	O
alters  	alters  	 VBG	O
the  	the  	 DT	O
potential  	potential  	 JJ	B-NP
interactions  	interactions  	 NNS	I-NP
formed  	formed  	 VBN	O
at  	at  	 IN	O
this  	this  	 DT	O
position 	position 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
is  	is  	 VBZ	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
have  	have  	 VB	O
a  	a  	 DT	O
small  	small  	 JJ	O
effect  	effect  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
overall  	overall  	 JJ	O
size  	size  	 NN	O
and  	and  	 CC	O
shape  	shape  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
molecule 	molecule 	 NN	B-NP
.  	.  	 .	O
Analog  	Analog  	 NNP	O
1  	1  	 CD	O
is  	is  	 VBZ	O
far  	far  	 RB	O
less  	less  	 RBR	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
lerisetron  	lerisetron  	 VB	O
and  	and  	 CC	O
more  	more  	 RBR	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
antagonist  	antagonist  	 NN	I-NP
granisetron 	granisetron 	 NN	I-NP
.  	.  	 .	O
Previous  	Previous  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
have  	have  	 VBP	O
shown  	shown  	 VBN	O
that  	that  	 IN	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
granisetron  	granisetron  	 NN	B-NP
is  	is  	 VBZ	O
not  	not  	 RB	O
affected  	affected  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
Y142A  	Y142A  	 JJ	O
mutation  	mutation  	 NN	O
[  	[  	 -LRB-	O
25  	25  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Analog  	Analog  	 NNP	O
1  	1  	 CD	O
may  	may  	 MD	O
bind  	bind  	 VB	O
more  	more  	 RBR	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
granisetron  	granisetron  	 VB	O
than  	than  	 IN	O
lerisetron  	lerisetron  	 NN	B-NP
and  	and  	 CC	O
thus  	thus  	 RB	O
would  	would  	 MD	O
be  	be  	 VB	O
unaffected  	unaffected  	 VBN	O
by  	by  	 IN	O
mutations  	mutations  	 NNS	O
at  	at  	 IN	O
Y142 	Y142 	 CD	B-NP
.  	.  	 .	O
This  	This  	 DT	O
is  	is  	 VBZ	O
less  	less  	 RBR	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
be  	be  	 VB	O
the  	the  	 DT	O
case  	case  	 NN	O
with  	with  	 IN	O
analog  	analog  	 CD	O
2 	2 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
strength  	strength  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
putative  	putative  	 JJ	B-NP
interaction  	interaction  	 NN	I-NP
at  	at  	 IN	O
Y142  	Y142  	 NNP	B-NP
can  	can  	 MD	O
be  	be  	 VB	O
identified  	identified  	 VBN	O
by  	by  	 IN	O
examining  	examining  	 VBG	O
the  	the  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
binding  	binding  	 VBG	O
of  	of  	 IN	O
lerisetron  	lerisetron  	 NN	B-NP
as  	as  	 IN	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Y142A  	Y142A  	 JJ	O
mutation 	mutation 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
Y142A  	Y142A  	 JJ	O
mutation  	mutation  	 NN	O
produced  	produced  	 VBD	O
a  	a  	 DT	O
160  	160  	 CD	O
fold  	fold  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
.  	.  	 .	O
This  	This  	 DT	O
change  	change  	 NN	O
reflects  	reflects  	 VBZ	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
energy  	energy  	 NN	B-NP
lost  	lost  	 VBD	O
as  	as  	 IN	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
alanine  	alanine  	 JJ	B-NP
substitution 	substitution 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
observed  	observed  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
Ki  	Ki  	 NNP	B-NP
on  	on  	 IN	O
wt  	wt  	 JJ	B-NP
receptors  	receptors  	 NN	I-NP
is  	is  	 VBZ	O
much  	much  	 RB	O
larger  	larger  	 JJR	O
than  	than  	 IN	O
that  	that  	 WDT	O
observed  	observed  	 VBD	O
for  	for  	 IN	O
removal  	removal  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	B-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
31  	31  	 CD	O
fold 	fold 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
but  	but  	 CC	O
is  	is  	 VBZ	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
that  	that  	 WDT	O
observed  	observed  	 VBD	O
for  	for  	 IN	O
substitution  	substitution  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
distal  	distal  	 JJ	I-NP
amino  	amino  	 JJ	I-NP
nitrogen  	nitrogen  	 NN	I-NP
in  	in  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
( 	( 	 -LRB-	O
400  	400  	 CD	O
fold 	fold 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Taken  	Taken  	 VBN	O
together  	together  	 RP	O
with  	with  	 IN	O
the  	the  	 DT	O
close  	close  	 JJ	O
structural  	structural  	 JJ	B-NP
similarity  	similarity  	 NN	I-NP
of  	of  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
to  	to  	 TO	O
lerisetron 	lerisetron 	 VB	O
,  	,  	 ,	O
it  	it  	 PRP	O
can  	can  	 MD	O
be  	be  	 VB	O
concluded  	concluded  	 VBN	O
that  	that  	 IN	O
comparison  	comparison  	 NN	O
of  	of  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
and  	and  	 CC	O
lerisetron  	lerisetron  	 NNS	B-NP
should  	should  	 MD	O
provide  	provide  	 VB	O
the  	the  	 DT	O
best  	best  	 JJS	O
means  	means  	 NNS	O
of  	of  	 IN	O
identifying  	identifying  	 VBG	O
the  	the  	 DT	O
interaction  	interaction  	 NN	O
at  	at  	 IN	O
Y142 	Y142 	 CD	B-NP
.  	.  	 .	O
No  	No  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
as  	as  	 IN	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Y142A  	Y142A  	 JJ	O
mutation  	mutation  	 NN	O
indicating  	indicating  	 VBG	O
a  	a  	 DT	O
lack  	lack  	 NN	O
of  	of  	 IN	O
any  	any  	 DT	O
significant  	significant  	 JJ	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
compound  	compound  	 NN	B-NP
with  	with  	 IN	O
Y142 	Y142 	 CD	B-NP
.  	.  	 .	O
These  	These  	 DT	O
data  	data  	 NNS	O
support  	support  	 VBP	O
our  	our  	 PRP$	O
hypothesis  	hypothesis  	 NN	O
that  	that  	 IN	O
Y142  	Y142  	 CD	B-NP
interacts  	interacts  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
piperazine  	piperazine  	 JJ	I-NP
nitrogen  	nitrogen  	 NN	I-NP
of  	of  	 IN	I-NP
lerisetron 	lerisetron 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
second  	second  	 JJ	O
amino  	amino  	 JJ	B-NP
acid  	acid  	 NN	I-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
involved  	involved  	 VBN	O
since  	since  	 IN	O
the  	the  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 JJ	B-NP
binding  	binding  	 NN	I-NP
as  	as  	 IN	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Y142A  	Y142A  	 JJ	O
mutation  	mutation  	 NN	O
was  	was  	 VBD	O
smaller  	smaller  	 JJR	O
than  	than  	 IN	O
the  	the  	 DT	O
change  	change  	 NN	O
produced  	produced  	 VBN	O
by  	by  	 IN	O
substitution  	substitution  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
piperazine  	piperazine  	 JJ	I-NP
nitrogen 	nitrogen 	 NN	I-NP
.  	.  	 .	O
As  	As  	 RB	O
described  	described  	 VBN	O
below 	below 	 RB	O
,  	,  	 ,	O
one  	one  	 CD	O
candidate  	candidate  	 NN	O
for  	for  	 IN	O
this  	this  	 DT	O
second  	second  	 JJ	O
amino  	amino  	 JJ	B-NP
acid  	acid  	 NN	I-NP
is  	is  	 VBZ	O
Y152 	Y152 	 CD	B-NP
.  	.  	 .	O
Functional  	Functional  	 JJ	B-NP
group  	group  	 NN	I-NP
interactions  	interactions  	 NNS	I-NP
of  	of  	 IN	I-NP
Y152  	Y152  	 CD	I-NP
The  	The  	 DT	O
Y152A  	Y152A  	 NNP	O
mutation  	mutation  	 VBD	O
produced  	produced  	 VBN	B-NP
increases  	increases  	 NNS	I-NP
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
all  	all  	 DT	O
three  	three  	 CD	O
compounds  	compounds  	 NN	O
although  	although  	 IN	O
the  	the  	 DT	O
magnitude  	magnitude  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
change  	change  	 NN	B-NP
differed 	differed 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
increases  	increases  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
values  	values  	 NNS	O
were  	were  	 VBD	O
190  	190  	 CD	O
fold  	fold  	 NN	O
for  	for  	 IN	O
lerisetron 	lerisetron 	 NN	B-NP
,  	,  	 ,	O
98  	98  	 CD	O
fold  	fold  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
1  	1  	 CD	O
and  	and  	 CC	O
only  	only  	 RB	O
40  	40  	 CD	O
fold  	fold  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
2 	2 	 CD	O
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
analog  	analog  	 CD	O
1  	1  	 CD	O
retains  	retains  	 VBZ	O
much  	much  	 RB	O
of  	of  	 IN	O
its  	its  	 PRP$	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
interact  	interact  	 VB	O
with  	with  	 IN	O
Y152  	Y152  	 CD	B-NP
despite  	despite  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
N-benzyl  	N-benzyl  	 JJ	I-NP
group 	group 	 NN	I-NP
,  	,  	 ,	O
while  	while  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
interacts  	interacts  	 NN	O
more  	more  	 RBR	O
weakly  	weakly  	 JJ	O
with  	with  	 IN	O
this  	this  	 DT	O
amino  	amino  	 JJ	B-NP
acid 	acid 	 NN	I-NP
.  	.  	 .	O
Since  	Since  	 IN	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
1  	1  	 CD	O
is  	is  	 VBZ	O
increased  	increased  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
Y152A  	Y152A  	 JJ	O
mutation 	mutation 	 NN	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
unlikely  	unlikely  	 JJ	O
that  	that  	 IN	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	B-NP
group  	group  	 NN	I-NP
interacts  	interacts  	 NN	O
with  	with  	 IN	O
Y152 	Y152 	 CD	B-NP
.  	.  	 .	O
The  	The  	 DT	O
small  	small  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
supports  	supports  	 VBZ	O
a  	a  	 DT	O
partial  	partial  	 JJ	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
Y152  	Y152  	 CD	B-NP
with  	with  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
piperazine  	piperazine  	 JJ	I-NP
nitrogen  	nitrogen  	 NN	I-NP
although  	although  	 IN	O
some  	some  	 DT	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
another  	another  	 DT	O
group  	group  	 NN	O
is  	is  	 VBZ	O
also  	also  	 RB	O
apparent 	apparent 	 JJ	O
.  	.  	 .	O
This  	This  	 DT	O
other  	other  	 JJ	O
group  	group  	 NN	O
would  	would  	 MD	O
be  	be  	 VB	O
expected  	expected  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
in  	in  	 IN	O
close  	close  	 JJ	O
proximity  	proximity  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
nitrogen 	nitrogen 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
most  	most  	 RBS	O
likely  	likely  	 JJ	O
candidate  	candidate  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
other  	other  	 JJ	O
nitrogen  	nitrogen  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
piperazine  	piperazine  	 JJ	I-NP
ring 	ring 	 NN	I-NP
.  	.  	 .	O
Thus  	Thus  	 RB	O
Y152A  	Y152A  	 CD	O
may  	may  	 MD	O
form  	form  	 VB	O
a  	a  	 DT	O
partial  	partial  	 JJ	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
both  	both  	 DT	O
piperazine  	piperazine  	 JJ	B-NP
nitrogens 	nitrogens 	 NN	I-NP
.  	.  	 .	O
Conclusions  	Conclusions  	 NNP	O
Figure  	Figure  	 NNP	O
6shows  	6shows  	 CD	O
a  	a  	 DT	O
hypothetical  	hypothetical  	 JJ	B-NP
model  	model  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
lerisetron-binding  	lerisetron-binding  	 JJ	I-NP
site  	site  	 NN	I-NP
supported  	supported  	 VBN	O
by  	by  	 IN	O
our  	our  	 PRP$	O
observations 	observations 	 NNS	B-NP
.  	.  	 .	O
The  	The  	 DT	O
model  	model  	 NN	O
illustrates  	illustrates  	 VBZ	O
the  	the  	 DT	O
secondary  	secondary  	 JJ	B-NP
structure  	structure  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
region  	region  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
from  	from  	 IN	O
Y140  	Y140  	 CD	B-NP
-  	-  	 :	O
Y152  	Y152  	 CD	B-NP
in  	in  	 IN	O
a  	a  	 DT	O
loop  	loop  	 JJ	O
configuration 	configuration 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
structure  	structure  	 NN	O
is  	is  	 VBZ	O
supported  	supported  	 VBN	O
by  	by  	 IN	O
site-directed  	site-directed  	 JJ	O
mutagenesis  	mutagenesis  	 JJ	B-NP
data  	data  	 NNS	I-NP
[  	[  	 -LRB-	O
25  	25  	 CD	O
]  	]  	 -RRB-	O
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
structural  	structural  	 JJ	B-NP
predictions  	predictions  	 NNS	I-NP
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
other  	other  	 JJ	O
LGIC  	LGIC  	 NN	B-NP
receptors  	receptors  	 NNS	I-NP
[  	[  	 -LRB-	O
31  	31  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
recent  	recent  	 JJ	O
determination  	determination  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
structure  	structure  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
nicotinic  	nicotinic  	 FW	B-NP
acetylcholine  	acetylcholine  	 FW	I-NP
binding  	binding  	 FW	I-NP
protein  	protein  	 FW	I-NP
[  	[  	 -LRB-	O
27  	27  	 CD	O
]  	]  	 -RRB-	O
that  	that  	 IN	O
shares  	shares  	 NNS	O
significant  	significant  	 JJ	O
homology  	homology  	 NN	B-NP
with  	with  	 IN	O
the  	the  	 DT	O
LGIC  	LGIC  	 NNP	B-NP
family  	family  	 NN	I-NP
also  	also  	 RB	O
supports  	supports  	 VBZ	O
a  	a  	 DT	O
loop  	loop  	 JJ	O
structure  	structure  	 NN	O
in  	in  	 IN	O
this  	this  	 DT	O
part  	part  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
protein 	protein 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
region  	region  	 NN	O
from  	from  	 IN	O
W89  	W89  	 CD	B-NP
through  	through  	 IN	O
Y93  	Y93  	 NNP	B-NP
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
β-sheet  	β-sheet  	 JJ	B-NP
as  	as  	 RB	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
hypothesized  	hypothesized  	 VBN	O
based  	based  	 VBN	O
on  	on  	 IN	O
site-directed  	site-directed  	 JJ	O
mutagenesis  	mutagenesis  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
strand  	strand  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	O
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
data  	data  	 NNS	O
indicate  	indicate  	 VBP	O
the  	the  	 DT	O
functional  	functional  	 JJ	B-NP
groups  	groups  	 NNS	I-NP
of  	of  	 IN	I-NP
lerisetron  	lerisetron  	 NNS	I-NP
that  	that  	 WDT	O
may  	may  	 MD	O
interact  	interact  	 VB	O
with  	with  	 IN	O
W89 	W89 	 NNP	B-NP
,  	,  	 ,	O
R91 	R91 	 NNP	B-NP
,  	,  	 ,	O
Y142  	Y142  	 NNP	B-NP
and  	and  	 CC	O
Y152 	Y152 	 NNP	B-NP
.  	.  	 .	O
W89  	W89  	 NNP	B-NP
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
interacting  	interacting  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
aromatic  	aromatic  	 JJ	B-NP
benzimidazole  	benzimidazole  	 JJ	I-NP
group  	group  	 NN	I-NP
of  	of  	 IN	I-NP
lerisetron  	lerisetron  	 NN	I-NP
although  	although  	 IN	O
the  	the  	 DT	O
precise  	precise  	 JJ	O
position  	position  	 NN	O
of  	of  	 IN	O
W89  	W89  	 CD	B-NP
relative  	relative  	 JJ	I-NP
to  	to  	 TO	O
this  	this  	 DT	O
group  	group  	 NN	O
is  	is  	 VBZ	O
not  	not  	 RB	O
known 	known 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
W89  	W89  	 JJ	B-NP
interaction  	interaction  	 NN	I-NP
with  	with  	 IN	O
this  	this  	 DT	O
group  	group  	 NN	O
is  	is  	 VBZ	O
supported  	supported  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
observed  	observed  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
lerisetron 	lerisetron 	 NN	B-NP
,  	,  	 ,	O
analog  	analog  	 CD	O
1  	1  	 CD	O
and  	and  	 CC	O
analog  	analog  	 CD	O
2 	2 	 CD	O
.  	.  	 .	O
Since  	Since  	 IN	O
the  	the  	 DT	O
benzimidazole  	benzimidazole  	 JJ	B-NP
group  	group  	 NN	I-NP
is  	is  	 VBZ	O
common  	common  	 JJ	O
to  	to  	 TO	O
all  	all  	 DT	O
three  	three  	 CD	O
compounds  	compounds  	 NN	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
the  	the  	 DT	O
most  	most  	 RBS	O
likely  	likely  	 JJ	O
point  	point  	 NN	O
of  	of  	 IN	O
interaction 	interaction 	 NN	O
.  	.  	 .	O
W89  	W89  	 NNP	B-NP
also  	also  	 RB	O
represents  	represents  	 VBZ	O
a  	a  	 DT	O
common  	common  	 JJ	O
interaction  	interaction  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
for  	for  	 IN	O
both  	both  	 DT	O
lerisetron  	lerisetron  	 NN	B-NP
and  	and  	 CC	O
[ 	[ 	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron 	granisetron 	 NN	B-NP
.  	.  	 .	O
Y142  	Y142  	 NNP	B-NP
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
interacting  	interacting  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
piperazine  	piperazine  	 NNS	I-NP
nitrogen  	nitrogen  	 VBP	O
possibly  	possibly  	 RB	O
through  	through  	 IN	O
a  	a  	 DT	O
cation-π  	cation-π  	 JJ	B-NP
interaction 	interaction 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
orientation  	orientation  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
amino  	amino  	 JJ	B-NP
group  	group  	 NN	I-NP
interacting  	interacting  	 NN	I-NP
with  	with  	 IN	O
an  	an  	 DT	O
aromatic  	aromatic  	 JJ	B-NP
amino  	amino  	 JJ	I-NP
acid  	acid  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
cation-π  	cation-π  	 JJ	B-NP
interaction  	interaction  	 NN	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
shown  	shown  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
nicotinic  	nicotinic  	 JJ	B-NP
acetylcholine  	acetylcholine  	 JJ	I-NP
receptor  	receptor  	 NN	I-NP
and  	and  	 CC	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
hypothesized  	hypothesized  	 VBN	O
for  	for  	 IN	O
many  	many  	 JJ	O
LGIC  	LGIC  	 NN	B-NP
receptors  	receptors  	 NNS	I-NP
[  	[  	 -LRB-	O
28  	28  	 CD	O
29  	29  	 CD	O
30  	30  	 CD	O
26  	26  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
conclusion  	conclusion  	 NN	O
is  	is  	 VBZ	O
based  	based  	 VBN	O
on  	on  	 IN	O
both  	both  	 PDT	O
the  	the  	 DT	O
magnitude  	magnitude  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
change  	change  	 NN	O
observed  	observed  	 VBD	O
on  	on  	 IN	O
the  	the  	 DT	O
wild  	wild  	 JJ	O
type  	type  	 NN	B-NP
receptor  	receptor  	 NN	I-NP
for  	for  	 IN	O
removal  	removal  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
amino  	amino  	 JJ	B-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
400  	400  	 CD	O
fold 	fold 	 CD	O
)  	)  	 -RRB-	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Y142A  	Y142A  	 JJ	O
mutation  	mutation  	 NN	O
on  	on  	 IN	O
lerisetron  	lerisetron  	 JJ	O
binding  	binding  	 NNS	O
( 	( 	 -LRB-	O
160  	160  	 CD	O
fold 	fold 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
the  	the  	 DT	O
lack  	lack  	 NN	O
of  	of  	 IN	O
any  	any  	 DT	O
major  	major  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
as  	as  	 IN	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
mutation 	mutation 	 NN	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
data  	data  	 NN	O
does  	does  	 VBZ	O
not  	not  	 RB	O
support  	support  	 VB	O
an  	an  	 DT	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
amino  	amino  	 JJ	B-NP
acid  	acid  	 NN	I-NP
with  	with  	 IN	O
either  	either  	 RB	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	B-NP
or  	or  	 CC	O
benzimidazole  	benzimidazole  	 JJ	B-NP
portions  	portions  	 NNS	I-NP
of  	of  	 IN	I-NP
lerisetron 	lerisetron 	 NN	I-NP
.  	.  	 .	O
Y152  	Y152  	 NNP	B-NP
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
positioned  	positioned  	 VBN	O
between  	between  	 IN	O
the  	the  	 DT	O
two  	two  	 CD	O
piperazine  	piperazine  	 CD	B-NP
nitrogens 	nitrogens 	 NNS	I-NP
.  	.  	 .	O
This  	This  	 DT	O
conclusion  	conclusion  	 NN	O
is  	is  	 VBZ	O
supported  	supported  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
smaller  	smaller  	 JJR	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
2  	2  	 CD	O
( 	( 	 -LRB-	O
40  	40  	 CD	O
fold 	fold 	 CD	O
)  	)  	 -RRB-	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
that  	that  	 WDT	O
observed  	observed  	 VBD	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 NNS	B-NP
( 	( 	 -LRB-	O
190  	190  	 CD	O
fold 	fold 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
suggest  	suggest  	 VBP	O
a  	a  	 DT	O
partial  	partial  	 JJ	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
Y152  	Y152  	 CD	B-NP
with  	with  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
piperazine  	piperazine  	 JJ	I-NP
nitrogen 	nitrogen 	 NN	I-NP
.  	.  	 .	O
Since  	Since  	 IN	O
some  	some  	 DT	O
change  	change  	 NN	O
was  	was  	 VBD	O
observed 	observed 	 VBN	O
,  	,  	 ,	O
a  	a  	 DT	O
second  	second  	 JJ	O
interaction  	interaction  	 NN	O
is  	is  	 VBZ	O
also  	also  	 RB	O
likely 	likely 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
functional  	functional  	 JJ	B-NP
group  	group  	 NN	I-NP
in  	in  	 IN	O
closest  	closest  	 JJS	O
proximity  	proximity  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
piperazine  	piperazine  	 JJ	I-NP
nitrogen  	nitrogen  	 NN	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
other  	other  	 JJ	O
nitrogen  	nitrogen  	 NN	B-NP
on  	on  	 IN	O
the  	the  	 DT	O
piperazine  	piperazine  	 JJ	B-NP
ring 	ring 	 NN	I-NP
.  	.  	 .	O
Another  	Another  	 DT	O
possibility  	possibility  	 NN	O
would  	would  	 MD	O
be  	be  	 VB	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	B-NP
interaction 	interaction 	 NN	I-NP
,  	,  	 ,	O
however 	however 	 RB	O
,  	,  	 ,	O
since  	since  	 IN	O
the  	the  	 DT	O
Y152A  	Y152A  	 JJ	O
mutation  	mutation  	 NN	O
also  	also  	 RB	O
produced  	produced  	 VBN	O
a  	a  	 DT	O
large  	large  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
analog  	analog  	 CD	O
2 	2 	 CD	O
,  	,  	 ,	O
this  	this  	 DT	O
conclusion  	conclusion  	 NN	O
is  	is  	 VBZ	O
not  	not  	 RB	O
supported  	supported  	 VBN	O
by  	by  	 IN	O
our  	our  	 PRP$	O
data 	data 	 NNS	O
.  	.  	 .	O
R91  	R91  	 NNP	B-NP
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
as  	as  	 IN	O
interacting  	interacting  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	B-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
is  	is  	 VBZ	O
a  	a  	 DT	O
difficult  	difficult  	 JJ	O
conclusion  	conclusion  	 NN	O
to  	to  	 TO	O
make  	make  	 VB	O
considering  	considering  	 VBG	O
the  	the  	 DT	O
small  	small  	 JJ	O
effect  	effect  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
R91A  	R91A  	 JJ	O
mutation  	mutation  	 NN	O
on  	on  	 IN	O
lerisetron  	lerisetron  	 JJ	B-NP
binding 	binding 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
interaction  	interaction  	 NN	O
is  	is  	 VBZ	O
included  	included  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
model  	model  	 NN	O
based  	based  	 VBN	O
on  	on  	 IN	O
structural  	structural  	 JJ	B-NP
information  	information  	 NN	I-NP
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
crystal  	crystal  	 NN	O
structure  	structure  	 NN	O
of  	of  	 IN	O
AChBP  	AChBP  	 NNP	B-NP
[  	[  	 -LRB-	O
27  	27  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
region  	region  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
protein  	protein  	 NN	B-NP
homologous  	homologous  	 NN	I-NP
to  	to  	 TO	O
loop  	loop  	 VB	O
E  	E  	 NN	O
and  	and  	 CC	O
loop  	loop  	 JJ	O
D  	D  	 NNP	O
of  	of  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3A  	3A  	 CD	O
receptor  	receptor  	 NN	O
suggests  	suggests  	 VBZ	O
a  	a  	 DT	O
loop  	loop  	 JJ	O
structure  	structure  	 NN	O
from  	from  	 IN	O
Y140  	Y140  	 CD	B-NP
to  	to  	 TO	O
Y152  	Y152  	 CD	B-NP
and  	and  	 CC	O
a  	a  	 DT	O
3-residue  	3-residue  	 NNP	O
turn  	turn  	 VBP	O
containing  	containing  	 VBG	O
a  	a  	 DT	O
glycine  	glycine  	 NN	B-NP
at  	at  	 IN	O
position  	position  	 NN	O
147  	147  	 CD	O
and  	and  	 CC	O
the  	the  	 DT	O
β-strand  	β-strand  	 JJ	B-NP
from  	from  	 IN	O
W89  	W89  	 CD	B-NP
through  	through  	 IN	O
Y93  	Y93  	 CD	B-NP
oriented  	oriented  	 VBN	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Figure  	Figure  	 NNP	O
6 	6 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
orientation  	orientation  	 NN	O
of  	of  	 IN	O
lerisetron  	lerisetron  	 NN	B-NP
between  	between  	 IN	O
W89  	W89  	 NNP	B-NP
and  	and  	 CC	O
Y142A  	Y142A  	 NNP	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
would  	would  	 MD	O
enable  	enable  	 VB	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	B-NP
group  	group  	 NN	I-NP
to  	to  	 TO	O
be  	be  	 VB	O
positioned  	positioned  	 VBN	O
in  	in  	 IN	O
close  	close  	 JJ	O
proximity  	proximity  	 NN	O
to  	to  	 TO	O
R91 	R91 	 CD	B-NP
.  	.  	 .	O
If  	If  	 IN	O
this  	this  	 DT	O
is  	is  	 VBZ	O
the  	the  	 DT	O
case 	case 	 NN	O
,  	,  	 ,	O
then  	then  	 RB	O
a  	a  	 DT	O
small  	small  	 JJ	O
alteration  	alteration  	 NN	O
in  	in  	 IN	O
position  	position  	 NN	O
of  	of  	 IN	O
analog  	analog  	 CD	O
1  	1  	 CD	O
or  	or  	 CC	O
2  	2  	 CD	O
in  	in  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
could  	could  	 MD	O
result  	result  	 VB	O
in  	in  	 IN	O
the  	the  	 DT	O
loss  	loss  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
presumably  	presumably  	 RB	O
weak  	weak  	 JJ	O
interaction 	interaction 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
apparent  	apparent  	 JJ	O
alterations  	alterations  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
location  	location  	 NN	O
of  	of  	 IN	O
analog  	analog  	 CD	O
1  	1  	 CD	O
would  	would  	 MD	O
be  	be  	 VB	O
consistent  	consistent  	 JJ	O
with  	with  	 IN	O
this  	this  	 DT	O
hypothesis 	hypothesis 	 NN	O
.  	.  	 .	O
An  	An  	 DT	O
alternate  	alternate  	 JJ	O
hypothesis  	hypothesis  	 NN	O
would  	would  	 MD	O
place  	place  	 VB	O
the  	the  	 DT	O
N-benzyl  	N-benzyl  	 JJ	B-NP
group  	group  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
different  	different  	 JJ	O
position 	position 	 NN	O
,  	,  	 ,	O
interacting  	interacting  	 VBG	O
with  	with  	 IN	O
another  	another  	 DT	O
amino  	amino  	 JJ	B-NP
acid 	acid 	 NN	I-NP
;  	;  	 :	O
either  	either  	 CC	O
solely  	solely  	 RB	O
or  	or  	 CC	O
in  	in  	 IN	O
concert  	concert  	 NN	O
with  	with  	 IN	O
R91 	R91 	 CD	B-NP
.  	.  	 .	O
Our  	Our  	 PRP$	O
data  	data  	 NNS	O
support  	support  	 VBP	O
a  	a  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	O
that  	that  	 IN	O
spans  	spans  	 VBG	O
the  	the  	 DT	O
D  	D  	 NNP	O
and  	and  	 CC	O
E  	E  	 NN	O
loop  	loop  	 NN	O
regions 	regions 	 NNS	O
.  	.  	 .	O
Table  	Table  	 NN	O
2shows  	2shows  	 VBZ	O
the  	the  	 DT	O
sequence  	sequence  	 JJ	B-NP
alignment  	alignment  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R 	R 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
α7  	α7  	 JJ	O
receptor  	receptor  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
AChBP  	AChBP  	 JJ	O
for  	for  	 IN	O
these  	these  	 DT	O
loops 	loops 	 NNS	O
.  	.  	 .	O
Sequence  	Sequence  	 JJ	B-NP
alignment  	alignment  	 NN	I-NP
of  	of  	 IN	O
mouse  	mouse  	 CD	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
AR 	AR 	 NNP	B-NP
,  	,  	 ,	O
α7  	α7  	 NNP	O
nAchR  	nAchR  	 NNP	O
and  	and  	 CC	O
AChBP  	AChBP  	 JJ	B-NP
result  	result  	 NN	I-NP
in  	in  	 IN	O
alignment  	alignment  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
proposed  	proposed  	 JJ	O
D  	D  	 NNP	O
and  	and  	 CC	O
E  	E  	 NN	B-NP
loop  	loop  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
AR  	AR  	 NN	B-NP
with  	with  	 IN	O
corresponding  	corresponding  	 JJ	O
regions  	regions  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
α7  	α7  	 NNP	O
nAchR  	nAchR  	 NNP	O
and  	and  	 CC	O
AChBP 	AChBP 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 JJ	I-NP
W89 	W89 	 NN	I-NP
,  	,  	 ,	O
R91  	R91  	 NNP	B-NP
Y140 	Y140 	 NNP	I-NP
,  	,  	 ,	O
Y142  	Y142  	 NNP	B-NP
and  	and  	 CC	O
Y152  	Y152  	 CD	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
5HT  	5HT  	 CD	I-NP
3  	3  	 CD	O
A  	A  	 DT	O
R  	R  	 NN	O
can  	can  	 MD	O
be  	be  	 VB	O
aligned  	aligned  	 VBN	O
with  	with  	 IN	O
W53 	W53 	 NNP	B-NP
,  	,  	 ,	O
Q55 	Q55 	 NNP	B-NP
,  	,  	 ,	O
L102 	L102 	 NNP	B-NP
,  	,  	 ,	O
R104 	R104 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
M114  	M114  	 CD	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
AChBP  	AChBP  	 JJ	O
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
6 	6 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
form  	form  	 VBP	O
a  	a  	 DT	O
cluster  	cluster  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
proposed  	proposed  	 JJ	O
acetylcholine  	acetylcholine  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
domain  	domain  	 NN	I-NP
of  	of  	 IN	O
AChBP  	AChBP  	 JJ	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
that  	that  	 DT	O
proposed  	proposed  	 VBN	O
in  	in  	 IN	O
our  	our  	 PRP$	O
model 	model 	 NN	O
.  	.  	 .	O
Both  	Both  	 DT	O
loops  	loops  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
identified  	identified  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
complementary  	complementary  	 JJ	B-NP
face  	face  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
nAChR 	nAChR 	 JJ	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
unknown  	unknown  	 VBN	O
if  	if  	 IN	O
lerisetron  	lerisetron  	 JJ	O
utilizes  	utilizes  	 JJ	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
principal  	principal  	 JJ	B-NP
face  	face  	 NN	I-NP
although  	although  	 IN	O
none  	none  	 NN	O
have  	have  	 VBP	O
been  	been  	 VBN	O
identified 	identified 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
model  	model  	 NN	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 JJ	B-NP
binding  	binding  	 NN	I-NP
will  	will  	 MD	O
be  	be  	 VB	O
further  	further  	 RB	O
refined  	refined  	 VBN	O
as  	as  	 IN	O
its  	its  	 PRP$	O
interactions  	interactions  	 NNS	B-NP
with  	with  	 IN	O
other  	other  	 JJ	O
binding  	binding  	 JJ	O
site  	site  	 NN	B-NP
amino  	amino  	 NN	I-NP
acids  	acids  	 NNS	I-NP
are  	are  	 VBP	O
investigated  	investigated  	 VBN	O
[  	[  	 -LRB-	O
26  	26  	 CD	O
32  	32  	 CD	O
33  	33  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Of  	Of  	 IN	O
particular  	particular  	 JJ	O
interest  	interest  	 NN	O
would  	would  	 MD	O
be  	be  	 VB	O
potential  	potential  	 JJ	B-NP
interactions  	interactions  	 NNS	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
N-benzyl  	N-benzyl  	 JJ	I-NP
group  	group  	 NN	I-NP
that  	that  	 WDT	O
would  	would  	 MD	O
account  	account  	 VB	O
for  	for  	 IN	O
the  	the  	 DT	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NN	B-NP
of  	of  	 IN	O
analog  	analog  	 CD	O
2 	2 	 CD	O
.  	.  	 .	O
Additional  	Additional  	 JJ	B-NP
information  	information  	 NN	I-NP
gained  	gained  	 VBD	O
from  	from  	 IN	O
comparison  	comparison  	 NN	O
of  	of  	 IN	O
our  	our  	 PRP$	O
model  	model  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
recent  	recent  	 JJ	O
crystal  	crystal  	 NN	O
structure  	structure  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
AChBP  	AChBP  	 JJ	O
demonstrates  	demonstrates  	 NN	O
that  	that  	 IN	O
lerisetron  	lerisetron  	 NNS	B-NP
can  	can  	 MD	O
be  	be  	 VB	O
roughly  	roughly  	 RB	O
' 	' 	 POS	O
fit 	fit 	 NN	O
'  	'  	 ''	O
into  	into  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
such  	such  	 JJ	O
that  	that  	 IN	O
all  	all  	 PDT	O
the  	the  	 DT	O
residues  	residues  	 JJ	B-NP
line  	line  	 NN	I-NP
up  	up  	 RB	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
our  	our  	 PRP$	O
model 	model 	 NN	O
.  	.  	 .	O
While  	While  	 IN	O
this  	this  	 DT	O
is  	is  	 VBZ	O
not  	not  	 RB	O
direct  	direct  	 JJ	O
evidence  	evidence  	 NN	O
that  	that  	 IN	O
the  	the  	 DT	O
model  	model  	 NN	O
is  	is  	 VBZ	O
correct 	correct 	 JJ	O
,  	,  	 ,	O
subsequent  	subsequent  	 JJ	O
molecular  	molecular  	 JJ	B-NP
modeling  	modeling  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
data  	data  	 NNS	O
presented  	presented  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
paper  	paper  	 NN	O
may  	may  	 MD	O
provide  	provide  	 VB	O
further  	further  	 JJ	O
support  	support  	 NN	O
for  	for  	 IN	O
our  	our  	 PRP$	O
hypothesis 	hypothesis 	 NN	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
current  	current  	 JJ	O
model  	model  	 NN	O
provides  	provides  	 VBZ	O
an  	an  	 DT	O
initial  	initial  	 JJ	O
working  	working  	 NN	B-NP
hypothesis  	hypothesis  	 NNS	I-NP
that  	that  	 WDT	O
can  	can  	 MD	O
form  	form  	 VB	O
the  	the  	 DT	O
basis  	basis  	 NN	O
of  	of  	 IN	O
further  	further  	 JJ	O
investigation 	investigation 	 NN	B-NP
.  	.  	 .	O
Also 	Also 	 RB	O
,  	,  	 ,	O
while  	while  	 IN	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
unclear  	unclear  	 JJ	O
whether  	whether  	 IN	O
the  	the  	 DT	O
information  	information  	 NN	O
obtained  	obtained  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
can  	can  	 MD	O
be  	be  	 VB	O
extended  	extended  	 VBN	O
to  	to  	 TO	O
other  	other  	 JJ	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
ligands 	ligands 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
similar  	similar  	 JJ	O
approach  	approach  	 NN	O
would  	would  	 MD	O
be  	be  	 VB	O
useful  	useful  	 JJ	O
in  	in  	 IN	O
identifying  	identifying  	 VBG	O
functional  	functional  	 JJ	B-NP
group  	group  	 NN	I-NP
interactions  	interactions  	 NNS	I-NP
for  	for  	 IN	I-NP
mCPBG 	mCPBG 	 NNP	I-NP
,  	,  	 ,	O
5-HT 	5-HT 	 NNP	O
,  	,  	 ,	O
dtC  	dtC  	 JJ	O
and  	and  	 CC	O
granisetron 	granisetron 	 NN	B-NP
.  	.  	 .	O
Materials  	Materials  	 NNS	O
and  	and  	 CC	O
Methods  	Methods  	 NNP	O
Mutagenesis  	Mutagenesis  	 NNP	O
Wild  	Wild  	 NNP	O
type  	type  	 FW	O
5-HT  	5-HT  	 FW	O
3AS  	3AS  	 FW	O
mouse  	mouse  	 FW	O
receptor  	receptor  	 FW	O
cDNA  	cDNA  	 NNP	O
was  	was  	 VBD	O
derived  	derived  	 VBN	O
from  	from  	 IN	O
N1E-115  	N1E-115  	 CD	O
neuroblastoma  	neuroblastoma  	 CD	O
cells  	cells  	 NNS	O
as  	as  	 IN	O
previously  	previously  	 RB	O
described  	described  	 VBN	O
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Mutant  	Mutant  	 JJ	O
receptors  	receptors  	 NNS	O
were  	were  	 VBD	O
constructed  	constructed  	 VBN	O
using  	using  	 VBG	O
polymerase  	polymerase  	 JJ	O
chain  	chain  	 NN	O
reaction  	reaction  	 NN	O
( 	( 	 -LRB-	O
Quick  	Quick  	 RB	O
change  	change  	 VB	O
mutagenesis  	mutagenesis  	 JJ	O
kit 	kit 	 NN	O
,  	,  	 ,	O
Promega 	Promega 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
All  	All  	 DT	O
mutations  	mutations  	 NN	O
were  	were  	 VBD	O
confirmed  	confirmed  	 VBN	O
by  	by  	 IN	O
DNA  	DNA  	 NNP	O
sequencing 	sequencing 	 NN	O
.  	.  	 .	O
Cell  	Cell  	 NN	O
culture  	culture  	 NN	O
methods  	methods  	 NNS	O
and  	and  	 CC	O
transfections  	transfections  	 CD	B-NP
tsA201  	tsA201  	 CD	I-NP
cells  	cells  	 NNS	I-NP
( 	( 	 -LRB-	O
a  	a  	 DT	O
derivative  	derivative  	 JJ	O
of  	of  	 IN	O
the  	the  	 DT	O
HEK293  	HEK293  	 JJ	B-NP
cell  	cell  	 NN	I-NP
line 	line 	 NN	I-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
grown  	grown  	 VBN	O
in  	in  	 IN	O
Dulbecco 	Dulbecco 	 NNP	O
's  	's  	 POS	O
modified  	modified  	 JJ	O
Eagles  	Eagles  	 JJ	O
medium  	medium  	 NN	O
( 	( 	 -LRB-	O
D-MEM 	D-MEM 	 NNP	O
)  	)  	 -RRB-	O
containing  	containing  	 VBG	O
10 	10 	 CD	O
%  	%  	 NN	O
FBS  	FBS  	 NNP	B-NP
and  	and  	 CC	O
100-units 	100-units 	 FW	O
/ 	/ 	 FW	O
ml  	ml  	 FW	O
penicillin 	penicillin 	 FW	O
/ 	/ 	 FW	O
streptomycin 	streptomycin 	 FW	O
.  	.  	 .	O
Cultures  	Cultures  	 NNS	O
were  	were  	 VBD	O
maintained  	maintained  	 VBN	O
in  	in  	 IN	O
humidified  	humidified  	 JJ	O
atmosphere  	atmosphere  	 NN	B-NP
of  	of  	 IN	O
5 	5 	 CD	O
%  	%  	 NN	O
CO  	CO  	 NNP	O
2  	2  	 CD	O
at  	at  	 IN	O
37°C 	37°C 	 CD	O
.  	.  	 .	O
For  	For  	 IN	O
binding  	binding  	 JJ	O
studies 	studies 	 NNS	O
,  	,  	 ,	O
tsA201  	tsA201  	 CD	B-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
plated  	plated  	 VBN	O
at  	at  	 IN	O
a  	a  	 DT	O
density  	density  	 NN	O
of  	of  	 IN	O
5  	5  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
6cells 	6cells 	 CD	O
/ 	/ 	 CD	O
75  	75  	 CD	O
cm  	cm  	 NNS	O
2and  	2and  	 VBP	O
grown  	grown  	 VBN	O
for  	for  	 IN	O
9  	9  	 CD	O
hours  	hours  	 NNS	O
prior  	prior  	 RB	O
to  	to  	 TO	O
transfection 	transfection 	 VB	O
.  	.  	 .	O
Cells  	Cells  	 NNS	O
were  	were  	 VBD	O
transfected  	transfected  	 VBN	O
with  	with  	 IN	O
10  	10  	 CD	O
μg  	μg  	 FW	O
murine  	murine  	 FW	O
5-HT  	5-HT  	 FW	O
3AS  	3AS  	 FW	O
R  	R  	 FW	O
cDNA  	cDNA  	 FW	O
using  	using  	 FW	O
calcium  	calcium  	 FW	B-NP
phosphate  	phosphate  	 FW	I-NP
co-precipitation  	co-precipitation  	 FW	I-NP
( 	( 	 -LRB-	O
New  	New  	 NNP	O
Life  	Life  	 NNP	O
Technologies 	Technologies 	 NNPS	O
,  	,  	 ,	O
NY 	NY 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
then  	then  	 RB	O
incubated  	incubated  	 CD	O
36  	36  	 CD	O
hours  	hours  	 NNS	O
prior  	prior  	 RB	O
to  	to  	 TO	O
harvesting 	harvesting 	 VB	O
.  	.  	 .	O
For  	For  	 IN	O
whole  	whole  	 JJ	O
cell  	cell  	 NN	O
patch  	patch  	 NN	O
clamp  	clamp  	 NN	O
experiments 	experiments 	 NNS	O
,  	,  	 ,	O
tsA201  	tsA201  	 CD	B-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
plated  	plated  	 VBN	O
at  	at  	 IN	O
a  	a  	 DT	O
density  	density  	 NN	O
of  	of  	 IN	O
0.25  	0.25  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
6cells 	6cells 	 CD	O
/ 	/ 	 CD	O
27  	27  	 CD	O
cm  	cm  	 CD	O
2dish  	2dish  	 CD	O
and  	and  	 CC	O
grown  	grown  	 VBN	O
12  	12  	 CD	O
hours  	hours  	 NNS	O
prior  	prior  	 RB	O
to  	to  	 TO	O
transfection 	transfection 	 VB	O
.  	.  	 .	O
Cells  	Cells  	 NNS	O
were  	were  	 VBD	O
washed  	washed  	 VBN	O
with  	with  	 IN	O
fresh  	fresh  	 JJ	O
culture  	culture  	 NN	O
medium  	medium  	 NN	O
then  	then  	 RB	O
transfected  	transfected  	 VBN	O
with  	with  	 IN	O
10  	10  	 CD	O
μg  	μg  	 CD	O
5-HT  	5-HT  	 CD	O
3AS  	3AS  	 CD	O
R  	R  	 NN	O
cDNA  	cDNA  	 NN	O
using  	using  	 VBG	O
Qiagen  	Qiagen  	 NNP	B-NP
Superfect  	Superfect  	 NNP	I-NP
transfection  	transfection  	 FW	I-NP
reagent  	reagent  	 FW	I-NP
( 	( 	 -LRB-	O
Qiagen 	Qiagen 	 NNP	B-NP
,  	,  	 ,	O
CA 	CA 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Transfected  	Transfected  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
this  	this  	 DT	O
mixture  	mixture  	 NN	O
for  	for  	 IN	O
2.5  	2.5  	 CD	O
hours 	hours 	 NNS	O
,  	,  	 ,	O
then  	then  	 RB	O
divided  	divided  	 VBN	O
into  	into  	 IN	O
35  	35  	 CD	O
mm  	mm  	 JJ	O
culture  	culture  	 NN	O
dishes  	dishes  	 NNS	O
at  	at  	 IN	O
a  	a  	 DT	O
density  	density  	 NN	O
of  	of  	 IN	O
approximately  	approximately  	 RB	O
5  	5  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
4cells 	4cells 	 CD	O
/ 	/ 	 CD	O
dish  	dish  	 NN	O
and  	and  	 CC	O
incubated  	incubated  	 NN	O
for  	for  	 IN	O
24  	24  	 CD	O
hours  	hours  	 NNS	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
before  	before  	 IN	O
recording 	recording 	 NN	O
.  	.  	 .	O
Radioligand  	Radioligand  	 NNP	B-NP
Binding  	Binding  	 NNP	I-NP
Assay  	Assay  	 NNP	I-NP
Transfected  	Transfected  	 NNP	I-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
scraped  	scraped  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
dishes 	dishes 	 NNS	O
,  	,  	 ,	O
washed  	washed  	 VBD	O
twice  	twice  	 RB	O
with  	with  	 IN	O
Dulbecco 	Dulbecco 	 NNP	O
's  	's  	 POS	O
PBS  	PBS  	 NNP	B-NP
( 	( 	 -LRB-	O
New  	New  	 NNP	O
Life  	Life  	 NNP	O
Technologies 	Technologies 	 NNPS	O
,  	,  	 ,	O
NY 	NY 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
then  	then  	 RB	O
resuspended  	resuspended  	 VBN	O
in  	in  	 IN	O
1.0  	1.0  	 CD	O
ml  	ml  	 JJ	B-NP
PBS 	PBS 	 NNP	I-NP
/ 	/ 	 CD	O
100  	100  	 CD	O
mm  	mm  	 JJ	O
dish 	dish 	 NN	O
.  	.  	 .	O
Cells  	Cells  	 NNS	O
were  	were  	 VBD	O
either  	either  	 RB	O
used  	used  	 VBN	O
fresh  	fresh  	 JJ	O
or  	or  	 CC	O
frozen  	frozen  	 VBN	O
at  	at  	 IN	O
this  	this  	 DT	O
step  	step  	 NN	O
until  	until  	 IN	O
needed 	needed 	 VBN	O
.  	.  	 .	O
Immediately  	Immediately  	 RB	O
prior  	prior  	 RB	O
to  	to  	 TO	O
use 	use 	 VB	O
,  	,  	 ,	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
homogenized  	homogenized  	 VBN	O
in  	in  	 IN	O
PBS  	PBS  	 NNP	B-NP
using  	using  	 VBG	O
a  	a  	 DT	O
glass  	glass  	 NN	O
tissue  	tissue  	 NN	O
homogenizer  	homogenizer  	 VBZ	O
then  	then  	 RB	O
centrifuged  	centrifuged  	 VBN	O
at  	at  	 IN	O
35  	35  	 CD	O
000  	000  	 CD	O
×  	×  	 CD	O
g  	g  	 NN	O
for  	for  	 IN	O
30  	30  	 CD	O
minutes  	minutes  	 NNS	O
in  	in  	 IN	O
a  	a  	 DT	O
Beckman  	Beckman  	 NNP	B-NP
JA20  	JA20  	 NNP	I-NP
rotor 	rotor 	 NN	I-NP
.  	.  	 .	O
Membranes  	Membranes  	 NNP	O
were  	were  	 VBD	O
washed  	washed  	 VBN	O
once  	once  	 RB	O
more  	more  	 JJR	O
with  	with  	 IN	O
PBS  	PBS  	 NNP	B-NP
then  	then  	 RB	O
resuspended  	resuspended  	 VBN	O
in  	in  	 IN	O
1  	1  	 CD	O
ml  	ml  	 JJ	B-NP
PBS 	PBS 	 NNP	I-NP
/ 	/ 	 CD	O
100  	100  	 CD	O
mm  	mm  	 JJ	O
dish 	dish 	 NN	O
.  	.  	 .	O
Protein  	Protein  	 NN	B-NP
content  	content  	 NN	I-NP
was  	was  	 VBD	O
determined  	determined  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
Lowry  	Lowry  	 JJ	B-NP
assay  	assay  	 NNS	I-NP
( 	( 	 -LRB-	O
Sigma 	Sigma 	 NNP	B-NP
.  	.  	 .	O
Diagnostics 	Diagnostics 	 NNP	O
,  	,  	 ,	O
St.  	St.  	 NNP	B-NP
Louis 	Louis 	 NNP	O
,  	,  	 ,	O
MO 	MO 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Binding  	Binding  	 JJ	O
assays  	assays  	 NN	O
were  	were  	 VBD	O
performed  	performed  	 VBN	O
in  	in  	 IN	O
PBS 	PBS 	 NNP	B-NP
.  	.  	 .	O
For  	For  	 IN	O
K  	K  	 NNP	O
d  	d  	 SYM	O
determinations 	determinations 	 FW	B-NP
,  	,  	 ,	O
100  	100  	 CD	O
μl  	μl  	 NN	B-NP
of  	of  	 IN	I-NP
homogenate  	homogenate  	 NN	I-NP
was  	was  	 VBD	O
incubated  	incubated  	 VBN	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
for  	for  	 IN	O
1  	1  	 CD	O
hour  	hour  	 NN	O
with  	with  	 IN	O
varying  	varying  	 VBG	B-NP
concentrations  	concentrations  	 NNS	I-NP
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
]  	]  	 -RRB-	O
granisetron  	granisetron  	 NNS	B-NP
( 	( 	 -LRB-	O
NEN 	NEN 	 NNP	B-NP
,  	,  	 ,	O
MA 	MA 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Specific  	Specific  	 JJ	O
binding  	binding  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
]  	]  	 -RRB-	O
granisetron  	granisetron  	 NN	B-NP
was  	was  	 VBD	O
determined  	determined  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
bound  	bound  	 NN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
]  	]  	 -RRB-	O
granisetron  	granisetron  	 VBZ	O
not  	not  	 RB	O
displaced  	displaced  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
saturating  	saturating  	 JJ	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	O
a  	a  	 DT	O
competing  	competing  	 JJ	O
ligand  	ligand  	 NNS	B-NP
( 	( 	 -LRB-	O
100  	100  	 CD	O
μM  	μM  	 JJ	B-NP
mCPBG  	mCPBG  	 JJ	I-NP
or  	or  	 CC	O
10  	10  	 CD	O
μM  	μM  	 JJ	B-NP
MDL-72222 	MDL-72222 	 CD	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
K  	K  	 NNP	O
d  	d  	 NN	O
values  	values  	 NNS	O
were  	were  	 VBD	O
determined  	determined  	 VBN	O
by  	by  	 IN	O
fitting  	fitting  	 VBG	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
data  	data  	 NNS	O
to  	to  	 TO	O
the  	the  	 DT	O
following  	following  	 JJ	O
equation  	equation  	 NN	O
using  	using  	 VBG	O
GraphPad  	GraphPad  	 JJ	B-NP
PRISM  	PRISM  	 NNP	I-NP
( 	( 	 -LRB-	O
San  	San  	 NNP	B-NP
Diego  	Diego  	 NNP	I-NP
CA 	CA 	 NNP	I-NP
) 	) 	 -RRB-	O
:  	:  	 :	O
B  	B  	 NNP	O
=  	=  	 NNP	O
Bmax  	Bmax  	 NNP	B-NP
[ 	[ 	 -LRB-	O
L 	L 	 NNP	O
]  	]  	 -RRB-	O
n  	n  	 FW	O
/  	/  	 FW	O
( 	( 	 -LRB-	O
[ 	[ 	 -LRB-	O
L 	L 	 NNP	O
]  	]  	 -RRB-	O
n  	n  	 FW	O
+  	+  	 FW	O
Kn 	Kn 	 FW	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
where  	where  	 WRB	O
θ  	θ  	 NN	O
is  	is  	 VBZ	O
bound  	bound  	 VBN	O
ligand 	ligand 	 NN	B-NP
,  	,  	 ,	O
Bmax  	Bmax  	 NNP	B-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
maximum  	maximum  	 JJ	B-NP
binding  	binding  	 NN	I-NP
at  	at  	 IN	O
equilibrium  	equilibrium  	 JJ	O
L  	L  	 NNP	O
is  	is  	 VBZ	O
the  	the  	 DT	O
free  	free  	 JJ	O
ligand  	ligand  	 JJ	B-NP
concentration  	concentration  	 NN	I-NP
and  	and  	 CC	O
n  	n  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
Hill  	Hill  	 NNP	O
coefficient 	coefficient 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
determinations 	determinations 	 FW	B-NP
,  	,  	 ,	O
100  	100  	 CD	O
μl  	μl  	 NN	B-NP
of  	of  	 IN	I-NP
homogenate  	homogenate  	 NN	I-NP
was  	was  	 VBD	O
incubated  	incubated  	 VBN	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
for  	for  	 IN	O
2  	2  	 CD	O
hours  	hours  	 NNS	O
with  	with  	 IN	O
varying  	varying  	 VBG	B-NP
concentrations  	concentrations  	 NNS	I-NP
of  	of  	 IN	O
inhibitor  	inhibitor  	 NN	O
and  	and  	 CC	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
]  	]  	 -RRB-	O
granisetron  	granisetron  	 NNS	B-NP
( 	( 	 -LRB-	O
NEN 	NEN 	 NNP	B-NP
,  	,  	 ,	O
MA 	MA 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Binding  	Binding  	 NNP	O
was  	was  	 VBD	O
terminated  	terminated  	 VBN	O
by  	by  	 IN	O
rapid  	rapid  	 JJ	B-NP
filtration  	filtration  	 NN	I-NP
onto  	onto  	 IN	O
a  	a  	 DT	O
GF 	GF 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
B  	B  	 NNP	I-NP
filters 	filters 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
IC  	IC  	 NNP	B-NP
50  	50  	 CD	O
values  	values  	 NNS	O
were  	were  	 VBD	O
calculated  	calculated  	 VBN	O
by  	by  	 IN	O
fitting  	fitting  	 VBG	O
the  	the  	 DT	O
data  	data  	 NNS	O
to  	to  	 TO	O
the  	the  	 DT	O
following  	following  	 JJ	O
equation  	equation  	 NN	O
using  	using  	 VBG	O
GraphPad  	GraphPad  	 JJ	B-NP
PRISM  	PRISM  	 NNP	I-NP
( 	( 	 -LRB-	O
San  	San  	 NNP	B-NP
Diego  	Diego  	 NNP	I-NP
CA 	CA 	 NNP	I-NP
) 	) 	 -RRB-	O
:  	:  	 :	O
θ  	θ  	 CD	O
=  	=  	 SYM	O
1 	1 	 CD	O
/  	/  	 CD	O
( 	( 	 -LRB-	O
1+ 	1+ 	 NNP	O
( 	( 	 -LRB-	O
L 	L 	 NNP	O
/ 	/ 	 NNP	O
IC  	IC  	 NNP	O
50  	50  	 CD	O
) 	) 	 -RRB-	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
where  	where  	 WRB	O
θ  	θ  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
fractional  	fractional  	 JJ	B-NP
amount  	amount  	 NN	I-NP
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
]  	]  	 -RRB-	O
granisetron  	granisetron  	 VBZ	O
bound  	bound  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
inhibitor  	inhibitor  	 NN	O
at  	at  	 IN	O
concentration  	concentration  	 NN	B-NP
L  	L  	 NNP	I-NP
as  	as  	 RB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
]  	]  	 -RRB-	O
granisetron  	granisetron  	 VBZ	O
bound  	bound  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	B-NP
of  	of  	 IN	O
inhibitor 	inhibitor 	 NN	O
.  	.  	 .	O
IC  	IC  	 NNP	B-NP
50  	50  	 CD	O
is  	is  	 VBZ	O
the  	the  	 DT	O
concentration  	concentration  	 NN	B-NP
at  	at  	 IN	O
which  	which  	 WDT	O
θ  	θ  	 VBD	O
=  	=  	 CD	O
0.5 	0.5 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
is  	is  	 VBZ	O
calculated  	calculated  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
IC  	IC  	 NNP	B-NP
50  	50  	 CD	O
value  	value  	 NN	O
using  	using  	 VBG	O
the  	the  	 DT	O
Cheng-Prusoff  	Cheng-Prusoff  	 JJ	B-NP
equation 	equation 	 NN	I-NP
.  	.  	 .	O
Electrophysiological  	Electrophysiological  	 NNP	B-NP
Methods  	Methods  	 NNP	I-NP
Transfected  	Transfected  	 NNP	I-NP
tsA201  	tsA201  	 NNP	I-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
transferred  	transferred  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
recording  	recording  	 NN	B-NP
chamber  	chamber  	 NN	I-NP
and  	and  	 CC	O
submerged  	submerged  	 NN	O
in  	in  	 IN	O
extracellular  	extracellular  	 JJ	B-NP
recording  	recording  	 NN	I-NP
buffer  	buffer  	 NN	I-NP
containing  	containing  	 VBG	O
25  	25  	 CD	O
mM  	mM  	 JJ	B-NP
HEPES  	HEPES  	 NNP	I-NP
pH  	pH  	 NNP	I-NP
7.4 	7.4 	 CD	O
,  	,  	 ,	O
140  	140  	 CD	O
mM  	mM  	 JJ	B-NP
NaCl 	NaCl 	 NN	I-NP
,  	,  	 ,	O
1.7  	1.7  	 CD	O
mM  	mM  	 JJ	O
MgCl  	MgCl  	 JJ	B-NP
2  	2  	 CD	O
,  	,  	 ,	O
5  	5  	 CD	O
mM  	mM  	 JJ	B-NP
KCl 	KCl 	 NN	I-NP
,  	,  	 ,	O
1.8  	1.8  	 CD	O
mM  	mM  	 JJ	O
CaCl  	CaCl  	 JJ	B-NP
2  	2  	 CD	O
.  	.  	 .	O
Patch  	Patch  	 JJ	O
electrodes  	electrodes  	 NNS	O
( 	( 	 -LRB-	O
2-2.5  	2-2.5  	 NNP	O
MΩ 	MΩ 	 NNP	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
filled  	filled  	 VBN	O
with  	with  	 IN	O
intracellular  	intracellular  	 JJ	B-NP
recording  	recording  	 NN	I-NP
buffer  	buffer  	 NN	I-NP
containing  	containing  	 VBG	O
25  	25  	 CD	O
mM  	mM  	 JJ	B-NP
HEPES  	HEPES  	 NNP	I-NP
pH  	pH  	 NNP	I-NP
7.4 	7.4 	 CD	O
,  	,  	 ,	O
145  	145  	 CD	O
mM  	mM  	 JJ	B-NP
KCL 	KCL 	 NNP	I-NP
,  	,  	 ,	O
2  	2  	 CD	O
mM  	mM  	 JJ	O
MgCl  	MgCl  	 JJ	B-NP
2  	2  	 CD	O
and  	and  	 CC	O
1  	1  	 CD	O
mM  	mM  	 JJ	B-NP
EGTA 	EGTA 	 NNP	I-NP
.  	.  	 .	O
Cells  	Cells  	 NNS	O
were  	were  	 VBD	O
clamped  	clamped  	 VBN	O
in  	in  	 IN	O
whole  	whole  	 JJ	O
cell  	cell  	 NN	O
configuration  	configuration  	 NN	O
at  	at  	 IN	O
a  	a  	 DT	O
holding  	holding  	 NN	B-NP
potential  	potential  	 NN	I-NP
of  	of  	 IN	O
-60  	-60  	 NNP	O
mV 	mV 	 NNP	O
.  	.  	 .	O
Currents  	Currents  	 JJ	O
elicited  	elicited  	 NN	O
by  	by  	 IN	O
agonist  	agonist  	 JJ	B-NP
application  	application  	 NN	I-NP
were  	were  	 VBD	O
measured  	measured  	 VBN	O
using  	using  	 VBG	O
an  	an  	 DT	O
Axopatch  	Axopatch  	 NNP	O
200B  	200B  	 FW	O
amplifier  	amplifier  	 FW	O
( 	( 	 -LRB-	O
Foster  	Foster  	 NNP	O
City 	City 	 NNP	O
,  	,  	 ,	O
CA 	CA 	 NNP	B-NP
)  	)  	 -RRB-	O
under  	under  	 IN	O
computer  	computer  	 NN	B-NP
control  	control  	 NN	I-NP
( 	( 	 -LRB-	O
DataPac  	DataPac  	 NNP	B-NP
2000 	2000 	 CD	O
,  	,  	 ,	O
RUN  	RUN  	 NNP	O
Technologies 	Technologies 	 NNPS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Agonists  	Agonists  	 NNP	B-NP
and  	and  	 CC	O
antagonists  	antagonists  	 NNS	O
were  	were  	 VBD	O
dissolved  	dissolved  	 VBN	O
in  	in  	 IN	O
extracellular  	extracellular  	 JJ	B-NP
solution  	solution  	 NN	I-NP
and  	and  	 CC	O
delivered  	delivered  	 VBN	O
to  	to  	 TO	O
cells  	cells  	 NNS	O
using  	using  	 VBG	O
a  	a  	 DT	O
rapid  	rapid  	 JJ	B-NP
perfusion  	perfusion  	 JJ	I-NP
system  	system  	 NN	I-NP
( 	( 	 -LRB-	O
Warner  	Warner  	 NNP	O
Instruments 	Instruments 	 NNP	O
,  	,  	 ,	O
Hamden 	Hamden 	 NNP	O
,  	,  	 ,	O
CT 	CT 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
For  	For  	 IN	O
EC  	EC  	 NNP	B-NP
50  	50  	 CD	O
determinations 	determinations 	 NN	B-NP
,  	,  	 ,	O
responses  	responses  	 NNS	O
were  	were  	 VBD	O
normalized  	normalized  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
maximum  	maximum  	 JJ	B-NP
response  	response  	 NN	I-NP
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
full  	full  	 JJ	O
agonist  	agonist  	 JJ	O
5-HT  	5-HT  	 NN	O
and  	and  	 CC	O
fitted  	fitted  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
equation  	equation  	 NN	O
Ψ=  	Ψ=  	 CD	O
1 	1 	 CD	O
/ 	/ 	 CD	O
1+ 	1+ 	 CD	O
( 	( 	 -LRB-	O
EC50 	EC50 	 NNP	O
/  	/  	 NNP	O
[ 	[ 	 -LRB-	O
C 	C 	 NNP	O
]  	]  	 -RRB-	O
n 	n 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
where  	where  	 WRB	O
Ψ  	Ψ  	 NNP	O
is  	is  	 VBZ	O
the  	the  	 DT	O
normalized  	normalized  	 JJ	O
current  	current  	 JJ	O
at  	at  	 IN	O
5-HT  	5-HT  	 CD	O
concentration  	concentration  	 NN	O
[ 	[ 	 -LRB-	O
C 	C 	 NNP	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
EC50  	EC50  	 NNP	B-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	O
5-HT  	5-HT  	 NNP	O
needed  	needed  	 VBD	O
to  	to  	 TO	O
obtain  	obtain  	 VB	O
half  	half  	 DT	O
maximal  	maximal  	 JJ	B-NP
activation  	activation  	 NN	I-NP
and  	and  	 CC	O
n  	n  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
apparent  	apparent  	 JJ	O
Hill  	Hill  	 NNP	O
coefficient 	coefficient 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
inhibition  	inhibition  	 JJ	B-NP
experiments 	experiments 	 NNS	I-NP
,  	,  	 ,	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
inhibitor  	inhibitor  	 VB	O
alone  	alone  	 RB	O
for  	for  	 IN	O
30  	30  	 CD	O
s  	s  	 VBZ	O
prior  	prior  	 RB	O
to  	to  	 TO	O
co-exposure  	co-exposure  	 JJ	B-NP
with  	with  	 IN	O
5-HT 	5-HT 	 CD	O
.  	.  	 .	O
Inhibited  	Inhibited  	 JJ	B-NP
responses  	responses  	 NNS	I-NP
were  	were  	 VBD	O
calculated  	calculated  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
fraction  	fraction  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
response  	response  	 NN	O
to  	to  	 TO	O
5-HT  	5-HT  	 CD	O
alone 	alone 	 RB	O
.  	.  	 .	O
Data  	Data  	 NNP	O
were  	were  	 VBD	O
plotted  	plotted  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
fractional  	fractional  	 JJ	O
response  	response  	 NN	O
versus  	versus  	 IN	O
the  	the  	 DT	O
concentration  	concentration  	 NN	O
of  	of  	 IN	O
inhibitor  	inhibitor  	 NN	O
and  	and  	 CC	O
analysed  	analysed  	 VBP	O
using  	using  	 VBG	O
GraphPad  	GraphPad  	 JJ	O
software 	software 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
IC  	IC  	 NNP	O
50  	50  	 CD	O
value  	value  	 NN	O
was  	was  	 VBD	O
calculated  	calculated  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
concentration  	concentration  	 NN	O
of  	of  	 IN	O
antagonist  	antagonist  	 NNS	O
inhibiting  	inhibiting  	 VBP	O
the  	the  	 DT	O
5-HT  	5-HT  	 JJ	O
evoked  	evoked  	 JJ	O
response  	response  	 NN	O
by  	by  	 IN	O
50 	50 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
value  	value  	 NN	O
was  	was  	 VBD	O
calculated  	calculated  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
IC  	IC  	 NNP	O
50  	50  	 CD	O
using  	using  	 VBG	O
the  	the  	 DT	O
Cheng-Prusoff  	Cheng-Prusoff  	 JJ	O
equation 	equation 	 NN	O
.  	.  	 .	O
Synthesis  	Synthesis  	 NNP	O
of  	of  	 IN	O
Lerisetron  	Lerisetron  	 NNP	B-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
analogs  	analogs  	 NNS	O
All  	All  	 DT	O
target  	target  	 NN	B-NP
molecules  	molecules  	 NNS	I-NP
were  	were  	 VBD	O
prepared  	prepared  	 VBN	O
according  	according  	 VBG	O
to  	to  	 TO	O
a  	a  	 DT	O
general  	general  	 JJ	O
2-step  	2-step  	 CD	O
synthesis  	synthesis  	 NNS	O
reported  	reported  	 VBD	O
previously  	previously  	 RB	O
by  	by  	 IN	O
Orjales  	Orjales  	 NNP	B-NP
et  	et  	 FW	O
al  	al  	 FW	O
.  	.  	 FW	O
with  	with  	 IN	O
only  	only  	 RB	O
slight  	slight  	 JJ	O
modification  	modification  	 NN	B-NP
[  	[  	 -LRB-	O
22  	22  	 CD	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Commercially  	Commercially  	 RB	O
available  	available  	 JJ	O
2-chlorobenzimidazole 	2-chlorobenzimidazole 	 NN	O
,  	,  	 ,	O
in  	in  	 IN	O
dry  	dry  	 JJ	O
DMF  	DMF  	 NNP	B-NP
was  	was  	 VBD	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
slight  	slight  	 JJ	O
excess  	excess  	 NN	O
of  	of  	 IN	O
NaH 	NaH 	 NNP	B-NP
,  	,  	 ,	O
( 	( 	 -LRB-	O
1.1eq 	1.1eq 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
After  	After  	 IN	O
stirring  	stirring  	 VBG	O
for  	for  	 IN	O
1  	1  	 CD	O
hour  	hour  	 NN	O
at  	at  	 IN	O
room  	room  	 NN	B-NP
temperature 	temperature 	 NN	I-NP
,  	,  	 ,	O
one  	one  	 CD	O
equivalent  	equivalent  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
appropriate  	appropriate  	 JJ	O
alkyl  	alkyl  	 JJ	B-NP
bromide  	bromide  	 NN	I-NP
was  	was  	 VBD	O
added  	added  	 VBN	O
slowly  	slowly  	 RB	O
and  	and  	 CC	O
the  	the  	 DT	O
reaction  	reaction  	 NN	B-NP
mixture  	mixture  	 VBZ	I-NP
heated  	heated  	 VBN	O
under  	under  	 IN	O
reflux  	reflux  	 NN	B-NP
for  	for  	 IN	O
>  	>  	 CD	O
5  	5  	 CD	O
hours  	hours  	 NNS	O
( 	( 	 -LRB-	O
the  	the  	 DT	O
reaction  	reaction  	 NN	O
was  	was  	 VBD	O
monitored  	monitored  	 VBN	O
by  	by  	 IN	O
TLC 	TLC 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Reaction  	Reaction  	 NN	B-NP
product  	product  	 NN	I-NP
was  	was  	 VBD	O
partitioned  	partitioned  	 VBN	O
between  	between  	 IN	O
water  	water  	 NN	O
and  	and  	 CC	O
methylene  	methylene  	 JJ	B-NP
chloride 	chloride 	 NN	I-NP
;  	;  	 :	O
organic  	organic  	 JJ	B-NP
layer  	layer  	 NN	I-NP
was  	was  	 VBD	O
dried  	dried  	 VBN	O
( 	( 	 -LRB-	O
Na  	Na  	 NNP	O
2  	2  	 CD	O
SO  	SO  	 CD	O
4  	4  	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
concentrated  	concentrated  	 VBN	O
in  	in  	 IN	O
vacuum 	vacuum 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
solid  	solid  	 JJ	O
residue  	residue  	 NN	O
was  	was  	 VBD	O
purified  	purified  	 VBN	O
by  	by  	 IN	O
Flash  	Flash  	 NNP	B-NP
chromatography 	chromatography 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
afforded  	afforded  	 VBZ	O
the  	the  	 DT	O
corresponding  	corresponding  	 JJ	O
N-substituted  	N-substituted  	 JJ	O
2-Chlorobenzimidazole  	2-Chlorobenzimidazole  	 CD	O
intermediates  	intermediates  	 NN	O
in  	in  	 IN	O
good  	good  	 JJ	O
yield 	yield 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
final  	final  	 JJ	B-NP
step  	step  	 NN	I-NP
involved  	involved  	 VBD	O
a  	a  	 DT	O
nucleophilic  	nucleophilic  	 JJ	B-NP
substitution  	substitution  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
2-chloro  	2-chloro  	 JJ	O
group  	group  	 NN	O
by  	by  	 IN	O
piperazine  	piperazine  	 NN	B-NP
at  	at  	 IN	O
high  	high  	 JJ	O
temperatures 	temperatures 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
reaction  	reaction  	 NN	O
was  	was  	 VBD	O
performed  	performed  	 VBN	O
neat  	neat  	 JJ	O
using  	using  	 VBG	O
4-10  	4-10  	 RB	O
fold  	fold  	 VB	O
excess  	excess  	 JJ	O
piperazine  	piperazine  	 NN	B-NP
and  	and  	 CC	O
typically  	typically  	 RB	O
heated  	heated  	 VBN	O
for  	for  	 IN	O
a  	a  	 DT	O
short  	short  	 JJ	O
period  	period  	 NN	O
only 	only 	 RB	O
,  	,  	 ,	O
( 	( 	 -LRB-	O
30-45  	30-45  	 FW	O
min 	min 	 FW	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Similar  	Similar  	 JJ	O
work-up  	work-up  	 NN	O
afforded  	afforded  	 VBN	O
a  	a  	 DT	O
residue  	residue  	 NN	O
that  	that  	 WDT	O
was  	was  	 VBD	O
purified  	purified  	 VBN	O
by  	by  	 IN	O
either  	either  	 DT	O
crystallization  	crystallization  	 NN	B-NP
or  	or  	 CC	O
chromatography 	chromatography 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
yields  	yields  	 NNS	O
ranged  	ranged  	 VBD	O
from  	from  	 IN	O
40-95 	40-95 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
All  	All  	 DT	O
compounds  	compounds  	 NN	O
were  	were  	 VBD	O
characterized  	characterized  	 VBN	O
by  	by  	 IN	O
NMR 	NMR 	 NNP	B-NP
,  	,  	 ,	O
MS 	MS 	 NNP	B-NP
,  	,  	 ,	O
HRMS 	HRMS 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
elemental  	elemental  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
or  	or  	 CC	O
were  	were  	 VBD	O
identical  	identical  	 JJ	O
to  	to  	 TO	O
literature  	literature  	 VB	B-NP
reports 	reports 	 NNS	I-NP
.  	.  	 .	O
Materials  	Materials  	 NNPS	O
D-MEM 	D-MEM 	 NNP	B-NP
,  	,  	 ,	O
Penicillin-Streptomycin 	Penicillin-Streptomycin 	 NNP	B-NP
,  	,  	 ,	O
fetal  	fetal  	 JJ	B-NP
bovine  	bovine  	 JJ	I-NP
serum 	serum 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
Trypsin  	Trypsin  	 NNP	B-NP
were  	were  	 VBD	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
New  	New  	 NNP	O
Life  	Life  	 NNP	O
Technologies.  	Technologies.  	 NNP	O
5-HT  	5-HT  	 NNP	O
and  	and  	 CC	O
MDL-72222  	MDL-72222  	 NNP	B-NP
were  	were  	 VBD	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
RBI.  	RBI.  	 NNP	B-NP
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
-granisetron  	-granisetron  	 NNP	O
( 	( 	 -LRB-	O
84  	84  	 CD	O
Ci 	Ci 	 CD	B-NP
/ 	/ 	 CD	I-NP
mmol 	mmol 	 CD	I-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
purchased  	purchased  	 VBN	O
from  	from  	 IN	O
New  	New  	 NNP	B-NP
England  	England  	 NNP	I-NP
Nuclear 	Nuclear 	 NNP	I-NP
.  	.  	 .	O
